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ABSTRACT 
 
THE MECHANISM OF CASPASE-8-MEDIATED GENE EXPRESSION AND ITS 
INTEGRAL ROLE IN HOST DEFENSE 
 
Alexandra Anne DeLaney 
 
Igor E. Brodsky, Ph.D. 
 
Caspase-8 is a key integrator of cell survival and cell death decisions during 
infection and inflammation. Additionally, caspase-8 has an important, but less understood, 
role in cell-intrinsic inflammatory gene expression. Macrophages lacking caspase-8 have 
defective inflammatory cytokine expression in response to bacterial infection or TLR 
stimulation. How caspase-8 regulates cytokine gene expression, and whether caspase-8-
mediated gene regulation has a physiological role during infection remains poorly defined. 
In this thesis we demonstrate that both caspase-8 enzymatic activity and scaffolding 
functions play a role in control of inflammatory cytokine gene expression. Caspase-8 
enzymatic activity mediates IKK phosphorylation and nuclear translocation of the NF-κB 
family member c-Rel to promote maximal expression of Il1b and Il12b. Overexpression of 
c-Rel was sufficient to restore expression of IL-12 and IL-1β in caspase-8-deficient cells. 
Moreover, the cytokine regulatory function of caspase-8 promoted host survival during 
infection by the intracellular parasite Toxoplasma gondii. Caspase-8-deficient mice 
displayed acute mortality during T. gondii infection and a defect in intracellular IL-12 
production by DCs. Exogenous IL-12 promoted complete survival of caspase-8-deficient 
mice during acute toxoplasmosis. Our findings provide new insight into how caspase-8 
controls inflammatory gene expression and, for the first time, identify a critical role for 
caspase-8 in host defense against a eukaryotic pathogen.  
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 1 
CHAPTER 1: Introduction 
1.1 Innate immune sensing  
The innate immune system is the first line of defense in the host response to insult 
or injury from the environment. Often this injury is triggered by attack from microbes such 
as bacteria, viruses, protozoan parasites, or prions. After a breach of physical barrier sites 
such as the skin, the innate immune system must (1) recognize this diverse group of 
microbes as a threat to the host, (2) activate inflammatory mediators to promote microbe 
clearance and host survival, and ultimately (3) trigger the adaptive immune response to 
promote long-term protection.  
For many years, addressing the way innate immune cells recognized such a diverse 
group of organisms in the absence of antigen specificity was an open question in the field 
of immunology. It was not until Dr. Charles Janeway proposed the Pattern Recognition 
framework—in which he hypothesized that innate immune cells recognize conserved 
microbial products known as Pathogen-Associated Molecular Patterns (PAMPs) through 
Pattern Recognition Receptors (PRRs) expressed on their surface—that immunologists had 
a comprehensive framework explaining how this process might occur in the host [1]. While 
Dr. Janeway’s prediction was not demonstrated experimentally until the mid 1990s [2-4], 
it has become a foundational pillar for our understanding of the ways in which host innate 
immune cells distinguish self from non-self. Subsequent groups have gone on to 
characterize a wide variety of PRRs that are expressed on the cell surface, intracellular 
membranes, and the cytoplasm [5, 6, 7, 8]. Moreover, we now know that PRRs are not 
restricted to innate immune cells, such as macrophages or dendritic cells, but are expressed 
on a variety of other immune cell types [9] as well as non-immune cells such as fibroblasts 
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[10] and epithelial cells [11-13]. PRR stimulation promotes functional alterations in these 
cell types that are critical for both immune activation and host homeostasis [14-16]. 
Recently our appreciation for the robust colonization of mammalian hosts by non-
self-microbes, such as the billions of bacteria and viruses in our intestinal tract [17], has 
raised a conceptual problem for the understanding of how PRR activation and 
inflammation target pathogenic microbes specifically. Under homeostatic conditions the 
host gut is not constitutively inflamed [18]. In fact it is hypothesized that commensal 
microbes conferred an evolutionary fitness advantage for our ancestors, allowing them to 
efficiently acquire nutrients and prevent colonization by pathobionts [19-21]. In exchange 
our guts provide a replicative niche for these commensals. How can we reconcile this with 
the knowledge that the PAMPs expressed by these commensal microbes are 
indistinguishable from pathogens? How does the host specifically promote clearance of 
pathogens while preserving beneficial microbes? One solution lies in the properties of the 
inflammatory networks activated in response to PRR stimulation. These networks are not 
on/off switches, rather they are regulated by a variety of intracellular factors that can 
dampen [22, 23] or heighten [24] the inflammatory signal. We are continually expanding 
the list of host factors that allow cells to fine-tune the inflammatory response. The aim of 
this thesis is to address the contribution of the cysteine protease caspase-8 to the regulation 
of inflammation in response to PRR activation, and to build upon our current understanding 
of the intracellular mechanisms that regulate activation in response to microbial products 
originating from both commensal and pathogenic organisms. 
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1.1.1 Overview of Toll-like-receptor activation and gene transcription. 
Toll-like receptors (TLRs) are a subset of PRRs that act as sensors for microbial 
products [2, 3, 25, 26]. TLRs can be expressed on the cell surface (TLR1, TLR2, TLR4, 
TLR5 [27], TLR6, and TLR10) or on endosomal membranes (TLR3 [28], TLR7 [29], 
TLR8, TLR9 [30], TLR11 [31], TLR12, and TLR13) [32]. Broadly, cell surface TLRs 
recognize microbial membrane components [33], and endosomal TLRs recognize 
microbial nucleic acids [34]. Activation of TLRs via the detection of PAMPs leads to the 
recruitment of the adapter proteins MyD88 (Myeloid differentiation primary response 88) 
and TRIF (TIR-domain-containing adapter-inducing interferon-β) [35-37].These adapter 
proteins mediate the induction of intracellular signaling cascades that ultimately activate 
the transcription factors NF-κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells), AP-1(Activator protein 1) and IRF3 (Interferon regulatory factor 3) [38, 39, 40]. 
These transcription factors in turn promote upregulation of inflammatory molecules that 
directly or indirectly promote killing of microbes [41-44](Figure 1.1). The roles of MyD88 
and TRIF are non-redundant as Myd88-/- and Trif-/- mice are differentially susceptible to 
infection with bacteria [45, 46] and viruses [35], respectively. TLR4, which recognizes a 
component of the cell wall of gram-negative bacteria known as lipopolysaccharide (LPS), 
is unique in that it is the only TLR that signals through both MyD88 and TRIF—MyD88 
when TLR4 is expressed at the plasma membrane and TRIF after TLR4 endocytosis [47, 
48]. Although TLRs signal through a common set of adaptor proteins (TLR4 and TLR3 
through TRIF and TLR4 along with all other TLRs through MyD88), it has been recently 
appreciated that the magnitude and breadth of this response is not uniform across all TLR-
stimuli [49]. This appreciation for the divergent activation of transcriptional responses 
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downstream of TLR stimulation has led to a body of work aimed at determining how 
signals from these common adaptors and transcription factors lead to unique gene 
expression patterns [50-52]. While significant progress has been made in defining the 
regulatory mechanisms by which common TLR-inputs are integrated into divergent gene 
expression outputs, these studies are by no means exhaustive, creating a gap in our 
knowledge surrounding one of the most fundamental aspects of the innate immune system. 
 
1.1.2  Overview of NF-κB-dependent gene regulation in macrophages. 
TLR-mediated activation of NF-κB induces the upregulation of pro-inflammatory 
mediators and antimicrobial peptides to promote killing of microbes [53-55]. NF-κB 
transcription factors are a family of five proteins that form active homo- and heterodimers 
to mediate gene expression [56](Figure 1.2). They are constitutively expressed in 
macrophages, and held in the cytoplasm by negative regulators from the IκB family; these 
negative regulators are degraded in response to TLR activation via the 26S proteasome [57, 
58](Figure 1.2). Degradation of IκB proteins allows NF-κB dimers to translocate to the 
nucleus and induce the expression of their target genes. NF-κB signaling is often used as a 
classic example of a negative feedback loop in biology, as the genes encoding inhibitory 
IκB proteins are among the many transcriptional targets for NF-κB dimers [59]. This 
provides an elegant mechanism to prevent chronic induction of inflammatory mediators 
triggered by TLR activation.  
In macrophages NF-κB gene targets can be categorized into primary and secondary 
response genes [60] that are thought to be organized by lineage determining factors 
expressed during macrophage development [61, 62]. As the name implies, primary 
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response genes are poised for rapid transcription due to their (1) open chromatin state, (2) 
limited occupation by nucleosomes, (3) independence from SWI/SNF-mediated chromatin 
modification, and (4) poised RNA polymerase II at their promoters [63-65]. However, 
secondary response genes require chromatin remodeling [66, 67] and RNA polymerase II 
recruitment to initiate transcription. Macrophage chromatin organization creates a temporal 
hierarchy for inflammatory gene expression through the division of gene accessibility to 
transcription factors such as NF-κB proteins [68, 69]. In macrophages the TLR4 agonist, 
LPS, is one of the most potent activators of NF-κB-dependent gene transcription, which is 
thought to be primarily dependent on the activity of p65 [70]. However, seminal work has 
shown that a less well-characterized NF-κB protein, c-Rel, is specifically required for the 
transcription of the secondary response gene Il12b [71], which encodes the IL-12p40 
subunit of IL-12p70 and IL-23, two cytokines essential for host defense against a variety 
of pathogens [72-74]. Data from our lab as well as others has shown a requirement for the 
cysteine protease caspase-8 in cytokine production in response to LPS and other TLR 
ligands such as Poly I:C (TLR3) and CpG (TLR9) [75-78]. Uniformly the gene we found 
to be most differentially affected by the absence of caspase-8 was Il12b [75]. Caspase-8 
affects Il12b transcription downstream of both TLR3, which is TRIF-dependent, and 
TLR9, which is MyD88-dependent. This suggests that in macrophages caspase-8 may 
serve as signaling node that enhances the magnitude of inflammatory cytokine expression 
in response to all TLRs regardless of their respective adaptor proteins. In Chapter 2 we 
identify the diversity of caspase-8-dependent genes induced in response to TLR4 and TLR9 
activation. 
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1.1.3 Overview of caspase-8 biology. 
Caspase-8 belongs to a family of pro-enzymes, termed caspases, which are 
activated by homodimerization and auto-processing [79-81]. Caspase-8 consists of tandem 
N-terminus death effector domains (DED) [82] that promote homotypic interactions 
between other DED-containing proteins, and a C-terminus catalytic domain that is auto-
processed during homodimerization to form the p20 and p10 subunits of the apoptotic 
formation of caspase-8 (Figure 1.3A). Upon activation of death receptors, such as TNFR 
(Tumor necrosis factor receptor) or Fas/CD95, the adaptor protein TRADD (Tumor 
necrosis factor receptor type 1-associated death domain protein) is recruited via homotypic 
interaction between its death domain and that of the death receptor [83, 84] (Figures 1.3B 
and 1.3C). TRADD then recruits FADD (FAS associated death domain), which contains 
both a death domain and death effector domain, thereby allowing for the recruitment of 
RIPK1 (Receptor-interacting serine/threonine-protein kinase 1) and caspase-8, 
respectively [85]. These proteins assemble to form the death inducing signaling complex 
(DISC) [86] then are rapidly endocytosed to form a cytoplasmic supramolecular complex 
known as Complex II [87]. Complex II serves as a platform for apoptotic signaling [87, 
88] (Figure 1.3C). Under pro-survival conditions, such as TNF stimulation, some death-
inducing proteins remain at the plasma membrane and promote activation of NF-κB and 
MAPK through TRADD-mediated recruitment of TRAF2 (TNFR associated factor 2) 
(Figures 1.1 and 1.3C) [89-94]. Under these pro-survival conditions, the expression of a 
catalytically inactive homolog of caspase-8, cFLIP (cellular FLICE like inhibitory protein), 
prevents caspase-8 auto-processing, thereby inhibiting caspase-8 apoptotic activity [91, 95, 
96]. TLR or TNFR stimulation coupled to chemical- or pathogen-mediated blockade of 
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gene transcription results in activation of Complex II, and a decrease in cFLIP expression 
[97-101]. These two signals promote the auto-processing of caspase-8 monomers and 
cleavage of downstream substrates to induce cell-extrinsic apoptosis (Figure 1.3C) [102, 
103].  
Recently, it has also been appreciated that caspase-8 constitutively represses 
another form of cell death known as programmed necrosis [104, 105]. Both the non-
apoptotic and apoptotic conformations of caspase-8 represses RIPK3- (Receptor-
interacting serine/threonine protein-kinase 3) mediated programmed necrosis through the 
constitutive cleavage of the lysine 63 deubiquitinase CYLD [106, 107]. CYLD cleaves 
K63 ubiquitin on RIPK1 promoting its dissociation from Complex II and promoting 
association with RIPK3 via homotypic interactions in their RHIM (RIP homotypic 
interaction motif) domains [108]. This interaction in turn leads to the phosphorylation of 
MLKL (Mixed lineage kinase domain like pseudokinase), oligomerization and plasma 
membrane disruption (Figure 1.3C) [109]. Previously, caspase-8-deficient animals were 
not viable because of the requirement for caspase-8-mediated repression of necrosis during 
embryonic development. The generation of Ripk3-/-Casp8-/- mice [104, 105] has provided 
a genetic tool to investigate the role of caspase-8 in inflammatory gene regulation without 
the confounding role of programmed necrosis. Using Ripk3-/-Casp8-/- mice as a tool, our 
lab, as well as other labs, have shown a role for caspase-8 in inflammatory cytokine 
production apart from its role in apoptosis and programmed necrosis [75-78, 110, 111]. 
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1.1.4 Caspase-8 mediates cytokine secretion. 
The enzymatic properties of caspase-8 that mediate cytokine secretion have yet to 
be elucidated. Caspase-8 likely has both scaffolding and enzymatic functions within the 
cell, but the relative contributions of scaffolding and enzymatic activity to gene expression 
has not been directly tested in response to TLR stimulation. Early it was reported that the 
pro-domains of caspase-8 were sufficient to mediate NF-κB signaling [78]. Recently, 
caspase-8 scaffolding has been implicated in TRAIL (TNF related apoptosis inducing 
ligand)-induced inflammatory gene expression in HeLa cells [112]. However, we 
previously observed that treatment of RIPK3-deficient macrophages with a caspase-8-
specific inhibitor reduced inflammatory cytokine production during TLR stimulation [75]. 
To address this potential discrepancy, and to mechanistically dissect the contribution of 
caspase-8 to macrophage inflammatory gene expression, we examined the roles of both 
caspase-8 scaffolding and enzymatic activities in regulation of NF-κB signaling. One 
approach we took to address this question was to generate a mouse expressing a 
catalytically active, non-cleavable form of caspase-8 in which the linker region between 
the p20 and p10 subunits is mutated from an aspartic acid to an alanine, inhibiting auto-
processing and stabilization of the apoptotic conformation of caspase-8 while preserving 
protein expression and its cytokine regulatory function (Figure 1.3A) [80, 113]. These 
mice will be referred to as Casp8DA/DA. We have previously shown that bone marrow 
derived macrophages (BMDMs) from these mice are resistant to apoptosis induced via 
infection with the gram-negative bacterial pathogen Yersinia pseudotuberculosis (Yp) [75]. 
Yp is a potent activator of caspase-8-dependent apoptosis in macrophages [97, 100, 114], 
but Casp8DA/DA BMDMs do not undergo apoptosis, and maintain their ability to secrete 
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inflammatory cytokines when stimulated with TLR ligands [75]. A combination of 
chemical inhibition of caspase-8 activity, genetic ablation of caspase-8, and specific 
mutation of caspase-8 apoptotic activity have allowed us to investigate both the mechanism 
by which caspase-8 regulates inflammatory gene expression (Chapter 2) in response to 
TLR stimulation, and the enzymatic requirements of caspase-8 in this context (Chapter 
3).  
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1.2 Role of apoptosis and cytokine secretion in host defense 
The hallmarks of inflammation—redness, swelling with heat, and pain—were first 
described by the Roman physician Cornelius Celsus in the first century A.D. [115]. 
Subsequent discoveries identified the soluble factors, which we now refer to as cytokines, 
that mediated some of the observed characteristics of inflammation, resulting in the 
identification of TNF in 1975 and IFN in 1978 [116-118]. Cytokines are defined as “soluble 
factor[s] produced by one cell and acting on another cell, in order to bring about a change 
in the function of the target cell” [119]. This broad definition encompasses an array of 
functions within the host of which signaling during inflammation is but one. The protective 
effect of cytokines has been appreciated since the observation that endotoxin-induced TNF 
was cytotoxic to tumor cells [116]. Moreover, in the early 80s Cantell and others began 
purifying bulk IFN preps from human donor cells stimulated with Sendai Virus for human 
clinical trials [120]. However, prolonged secretion of cytokines can also have detrimental 
effects, and chronic inflammation mediated by cytokines has been implicated in diseases 
such as diabetes, rheumatoid arthritis, Crohn’s disease, and plaque psoriasis [121-124]. As 
such there is considerable interest in identifying the mechanisms by which the host immune 
system secretes inflammatory mediators to promote acute clearance of pathogens, but 
controls long-term release to prevent tissue damage and host mortality.  
A second line of defense in control of microbial infection is programmed cell death, 
which allows the host to destroy the infected cell, control pathogen spread, and promote 
the release of danger-associated molecular patterns (DAMPs) that signal to bystander cells. 
Both caspase-8 enzymatic activity and scaffolding are implicated in many of these 
programmed cell death pathways. Caspase-8 plays a role in host defense during pyroptosis 
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[77, 125, 126], programmed necrosis [127], and apoptosis [128] during both viral and 
bacterial infection. Apoptosis is unique in that under developmental and homeostatic 
conditions it is largely thought to be immunologically silent [129]. However, there are 
contexts in which apoptosis can be inflammatory [130, 131], particularly when it is coupled 
to infection [98, 132].  In investigating the role of apoptosis in host defense we discovered 
that the caspase-8 serves as a bridge between the regulation of cell death and cytokine 
production in response to PAMP stimulation [75]. Given the role of both cell death and 
cytokine production in host defense during infection we sought to determine the relative 
contributions of both caspase-8-mediated cytokine secretion and caspase-8-mediated cell 
death in this context.  
 
1.2.1. Caspase-8 deficiency leads to embryonic lethality.  
Caspase-8 negatively regulates programmed necrosis through the constitutive 
cleavage of the lysine 63 deubiquitinase CYLD [133]. For this reason, the single ablation 
of caspase-8 results in lethality ten days into embryonic development. Dual ablation of 
caspase-8 and RIPK3, a mediator of programmed necrosis, yield viable mice with normal 
development [104, 105]. However, beginning at 6 weeks Ripk3-/-Casp8-/- mice display 
lymphadenopathy and splenomegaly that is attributed to the accumulation of lymphocytes, 
specifically a CD4-CD8-CD3+B220+ adaptive population of T cells [105]. Conditional 
deletion of caspase-8 using the Cre/LoxP system in specific cell lineages leads to activation 
of programed necrosis upon cell stimulation [107, 134]. Therefore, Ripk3-/-Casp8-/- mice 
are currently the best tool to study caspase-8-mediated apoptosis and cytokine secretion 
during host defense in vivo. Recently, we have also generated a mouse, Casp8DA/DA, 
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sufficient for the cytokine regulatory function of caspase-8, but not its apoptotic activity 
(Section 1.1.4) [75]. These mice were also bred to Ripk3-/- mice to create Ripk3-/-
Casp8DA/DA mice. Ripk3-/-Casp8DA/DA mice should not be able to undergo apoptosis or 
programmed necrosis, but should be able to produce caspase-8-dependent inflammatory 
cytokines. We have performed preliminary characterizations of the developmental 
phenotype of these mice that will be described in Chapter 4 as well as infections with 
Toxoplasma gondii and Yersinia pseudotuberculosis that are discussed in Chapters 5 and 
6, respectively.  
 
1.2.2 Role of caspase-8 in host survival during acute Toxoplasma gondii infection. 
The protozoan parasite T. gondii infects warm-blooded animals via ingestion of 
oocysts shed in the feces of the parasites’ obligate hosts: members of Felidae family 
(domestic cats) [135]. The CDC estimates that 40 million adults, adolescents, and children 
are infected at any given time in the U.S., and that Toxoplasma spp. are the leading cause 
of foodborne-related deaths [136]. Early work investigating the mechanisms of immune 
protection against T. gondii-infection identified the cytokine IL-12p70 as a key mediator 
of host defense [137]. C57BL/6 mice clear infection with the attenuated Prugniaud (Pru) 
strain of T. gondii within 30 days, and this clearance is dependent on the early production 
of IL-12p70 [138]. IL-12p70 secreted by conventional dendritic cells (cDCs) promotes 
early release of NK cell IFNγ as well as a CD4 and CD8 T cell recruitment [139]. These 
events lead to myeloid- and T-mediated killing of infected cells [140-143].  
Interestingly, the cytokine that is most affected by the loss of caspase-8 is IL-12p40 
[75], but to our knowledge no one had identified a role for caspase-8 in protection against 
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T. gondii. Caspase-8-mediated apoptosis is not thought to play a role in host defense during 
T. gondii infection as the parasite actively suppresses apoptotic signaling [144, 145]. For 
these two reasons we hypothesized that caspase-8-mediated cytokine production—not cell 
death—is required for survival during acute T. gondii infection. The results from these 
studies are described in Chapter 5.  
 
1.2.3 Caspase-8 mediates host survival in response to Yersinia pseudotuberculosis. 
Previous work from our lab as well as others has shown that caspase-8 plays a cell-
intrinsic role in cytokine production in response to gram-negative bacterial infections [75-
77, 100, 110, 146] and fungal infections [147]. These data suggest that caspase-8-
dependent cytokine production may promote antimicrobial host defense independently of 
its apoptotic activity. One potent activator of caspase-8-dependent apoptosis and cytokine 
production is Yersinia pseudotuberculosis, a gram-negative bacterial pathogen that causes 
self-limiting gastroenteritis in humans [148, 149], but in mice mimics infection with the 
related species Yersinia pestis, the causative agent of plague [150-152]. Yersinia pestis is 
still endemic in the United States, with a mortality rate between 30-90% when left untreated 
[153], making it not only a model to dissect the dual functions of caspase-8 in host defense, 
but also a pathogen of broad public health relevance. Yersinia pseudotuberculosis 
expresses seven effector proteins known as Yersinia outer proteins (Yops) that are injected 
into target cells through a needle like structure known as the Type III secretion system 
[154, 155]. One of these effectors, YopJ, blocks MAPK and NF-κB signaling, leading to 
the activation of caspase-8-mediated apoptosis (Figure 1.5) [154]. Injection of YopJ occurs 
within the first hour of infection and results in irreversible cell death within 4 hours in vitro 
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[132, 156]. We have previously shown that sublethally irradiated C57BL/6 mice 
reconstituted with Ripk3-/-Casp8-/- bone marrow infected orally with Yersinia 
pseudotuberculosis have a cell-intrinsic defect in cytokine secretion, and an acute survival 
defect [114]. However, these data do not address whether caspase-8-mediated apoptosis or 
caspase-8-mediated cytokine production promote host survival in this context. Therefore, 
we sought to determine the relative contributions of both caspase-8-mediated cell death 
and inflammatory cytokine production to host survival during infection with Yersinia 
pseudotuberculosis (Chapter 6).  
 
1.2.4 Caspase-8 deficiency in humans leads to acute susceptibility to microbial infection. 
A majority of the mechanistic research interrogating the apoptotic- and immune 
signaling-functions of caspase-8 have been performed using mice and mouse cells. 
However, there are humans with a caspase-8 deficiency. These patients were identified in 
2001 as a brother and sister whose asymptomatic parents possessed a heterozygous 
mutation that rendered caspase-8 catalytically inactive and the protein unstable [157]. The 
clinical history of these patients revealed ongoing, acute susceptibility to microbial 
infections, suggesting that caspase-8-induced control of cell death contributes to 
antimicrobial defense [157]. However, B, NK, and T cells from these patients had defects 
in activation, which was attributed to impaired NF-κB signaling mediated through caspase-
8 [78, 157-159]. These data raised the possibility that these patients’ susceptibility to 
microbial infection may involve caspase-8-mediated control of immune cell activation in 
lieu of caspase-8-mediated cell death.  
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Subsequent studies investigating the role of caspase-8 in T cell activation in mice 
using the dual ablation of caspase-8 and RIPK3 showed no defects in T cell activation or 
defects in T cell expansion after infection with LCMV Armstrong (Lymphocytic 
Choriomeningitis virus) or MHV (Mouse Herpes virus) [134, 160]. One explanation of this 
discrepancy is that there are human- and mouse-specific signaling mechanisms that dictate 
the differential impact of caspase-8 on immune cell activation. It also possible that this 
difference can be attributed to the expression of the caspase-8 homolog caspase-10 in 
humans and not rodents [161]. In fact, redundancy between caspase-8 and caspase-10 in 
humans was offered as an explanation for the ability of humans to survive embryonic 
development without functional caspase-8 [157]. However, we are optimistic that our 
investigations of caspase-8 in inflammatory gene expression and host defense will provide 
some basis for further investigations into caspase-8-specific functions in human immune 
cells.  
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1.3 Summary  
Caspase-8 is uniquely poised at the interface of cell death and cytokine 
production—two essential biological processes that mediate host defense. Understanding 
both (1) the mechanism of caspase-8 dependent cytokine production and (2) the relative 
contributions of caspase-8-mediated cell death and cytokine secretion to host survival will 
allow us to elucidate how host immune cells are able to switch between expression of pro-
inflammatory mediators and cell death during infection.  The aim of this project was to 
begin to resolve two conceptual and scientific gaps in the field of caspase-8 biology, 
thereby expanding our understanding of the intimate integration of inflammation and cell 
death.  
One gap in knowledge was the structural requirements of caspase-8 that mediate its 
immune regulatory function. Some hypothesize that caspase-8 serves as a scaffolding 
platform for signal transduction that leads to gene expression [111, 112]. However, data 
from our lab suggest that caspase-8 enzymatic activity is required for maximal cytokine 
expression [75]. Chapters 2 and 3 seek to address this question in the context of 
macrophage gene expression.  
The second gap is the broader question of the mechanism by which caspase-8 
promotes host defense. Given the observation that humans with caspase-8 deficiencies 
experience chronic infection with a variety of pathogens, and the requirement for caspase-
8 in mouse survival during infection with Yersinia pseudotuberculosis, we sought to 
address the question of what biological property or properties of caspase-8 contribute to 
host protection. Previous work from our lab as well as others has demonstrated a broad 
cell-intrinsic role for caspase-8 in the regulation of immune cell homeostasis, inflammatory 
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cell death, and inflammatory gene expression. The spectrum of caspase-8 cellular functions 
provide several potential mechanisms by which caspase-8 promotes host survival during 
microbial infection. Data from Chapters 5 and 6 seek to address this question during acute 
infection with Toxoplasma gondii and Yersinia pseudotuberculosis, respectively.  
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1.4 Figures  
 
Fig 1.1 Schematic of signal transduction induced in response to TLR stimulation[162, 163]. 
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Fig 1.2 Schematic of NF-κB and IκB protein structure [56].  
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Fig 1.3 Schematic of proteins involved in death receptor signaling and the signal 
transduction cascade that mediates apoptosis and programmed necrosis [83, 87, 96].  
  
 21 
 
Fig 1.4. Model of IL-12-mediated clearance of Toxoplasma gondii infection.   
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Fig 1.5 Schematic of Yersinia pseudotuberculosis-induced apoptosis in macrophages.  
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CHAPTER 2: Caspase-8 regulates TLR-induced macrophage gene 
expression through the NF-κB family member c-Rel. 
2.1 Abstract  
Our group as well as others have shown that caspase-8 has an important role in cell-
intrinsic inflammatory gene expression. Macrophages lacking caspase-8 or the adaptor 
protein FADD have defective inflammatory cytokine expression, and inflammasome 
priming in response to bacterial infection and TLR stimulation. Macrophage cytokine 
secretion is a key regulator of host innate immunity. Therefore, defining the regulatory 
mechanisms that promote macrophage-mediated cytokine expression are essential to the 
development of clinical therapies that target these signaling pathways. We sought to 
specifically define the mechanism of caspase-8-dependent gene regulation in the context 
of TLR stimulation. Here we demonstrate that caspase-8 regulates a broad repertoire of 
inflammatory genes in response to multiple TLRs, and that caspase-8 exerts this function 
in part through regulation of IKK phosphorylation. This differential IKK phosphorylation 
affects translocation of the NF-κB family member c-Rel, but not p65, and overexpression 
of c-Rel was sufficient to restore expression of IL-12 and IL-1β in caspase-8-deficient cells. 
IKK phosphorylation in response to TLR4 and TLR9 is dependent on the presence of the 
adaptor protein FADD suggesting a mechanism by which both TLR activation and death 
receptor activation are coupled to caspase-8 signaling in macrophages. These findings 
provide new insight into a novel regulatory mechanism for the transcription factor c-Rel 
via caspase-8-mediated activation of IKK phosphorylation.   
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2.2 Introduction 
Caspase-8-mediated apoptosis plays a critical role in immune homeostasis through 
the clearance of autoreactive cells [164-166], and tumor suppression [167]. Therefore, 
there has been considerable effort in elucidating the regulatory mechanisms governing this 
form of cell death. These studies have helped identify the critical adaptor molecules FADD 
[168, 169] and TRADD [170] that mediate caspase-8-recruitment to the death receptors 
Fas and TNFR1/2 respectively as well as the signals that govern the switch from pro-
survival signaling at the plasma membrane to apoptotic signaling via Complex II in the 
cytoplasm [92, 93]. However, there is evidence that caspase-8 plays a role in host survival 
beyond its role in cell-extrinsic apoptosis.  
Original reports of caspase-8 mutations in humans identified defects in T, B and 
NK cell activation [157], and subsequent work demonstrated that caspase-8 regulates 
NF-κB activation through interactions with NIK (NF-κB-inducing kinase) and RIKP1 [78]. 
These data led to the hypothesis that caspase-8 regulates lymphocyte activation through 
NF-κB signaling. This mechanism that was seemingly confirmed by subsequent studies in 
mice showing a role for caspase-8 in B cell survival in response to TLR stimulation, and 
decreased NF-κB signaling in the absence of caspase-8 in other cell types [158, 159]. 
However, two seminal studies published simultaneously in 2011 demonstrated a role for 
caspase-8 in the repression of another cell death pathway: programmed necrosis [104, 105]. 
In the absence of caspase-8 there is a de-repression of RIPK1/RIPK3-dependent 
programmed necrosis during embryonic development [92, 104, 105]. Dual ablation of 
caspase-8 and RIPK3 led to viable progeny, and abrogated the constitutive activation of 
programmed necrosis in response to death-inducing stimuli [105]. It was also shown that 
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caspase-8 negatively regulates programmed necrosis through the constitutive cleavage of 
the deubiquitinase CYLD [133]. CYLD cleaves K63 ubiquitin on RIPK1 which leads to 
its interaction with RIPK3 and subsequent activation of programmed necrosis [106].  
These new data raised the possibility that previous studies demonstrating a role for 
caspase-8 in NF-κB signaling downstream of lymphocyte activation were confounded by 
the role of caspase-8 in the regulation of programmed necrosis. It was possible that the 
observed phenotype in lymphocytes was due to a defect in survival and not activation. In 
fact studies testing the impact of dual ablation of caspase-8-dependent apoptosis and 
RIPK3-mediated programmed necrosis in T cells showed no defect in proliferation—these 
mice also display normal T cell activation after infection with MHV [160]. These data 
conflict with earlier reports that caspase-8 was required for T cell activation in humans: 
T cells isolated from caspase-8-deficient patients had a decrease in IL-2 release after TCR 
stimulation [157]. However, these earlier studies did not test if these cells were dying in 
response to TCR activation which is a possible experimental outcome given our current 
understanding of caspase-8-dependent regulation of programmed necrosis. Another 
potential explanation for this discrepancy is that there are mouse- and human-specific 
differences in T cell activation after TCR stimulation, but these investigators did not 
directly test cell death in these cultures so this conflict remains unresolved.  
Our initial interest in caspase-8 biology arose from its role in cell death in response 
to microbial infection. It has long been appreciated that apoptosis promotes clearance of 
virally infected cells, illustrated by the evolution of viral antagonism of caspase-8-mediated 
apoptosis [171, 172]. However, the role of caspase-8 in response to bacterial infection has 
yet to be completely defined. The gram-negative bacterial pathogen Yersinia 
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pseudotuberculosis (Yp), causes self-limiting gastroenteritis in humans, but in mice leads 
to bacterial dissemination that is similar to the systemic infection that is observed in 
humans infected with the related species Yersinia pestis—the causative agent of plague 
[148, 151]. Y. pseudotuberculosis is a potent activator of caspase-8-dependent apoptosis in 
macrophages [154, 173], and it was initially hypothesized that this induction of death 
mediated virulence in infected mice. However, strains of Y. pseudotuberculosis that induce 
less cell death in vitro have increased virulence in vivo [174], suggesting that caspase-8-
mediated apoptosis is a host-derived mechanism of limiting virulence and dissemination 
of Y. pseudotuberculosis. These data suggest that caspase-8-medaited apoptosis is 
protective in the context of oral Y. pseudotuberculosis infection. 
In an effort to determine the role of caspase-8-mediated apoptosis in immune cells 
during bacterial infection in vivo we generated bone marrow chimeras by transferring B6, 
Ripk3-/-, and  Ripk3-/-Casp8-/- bone marrow progenitors into sublethally C57BL/6 mice. 
Consistent with the hypothesis that caspase-8-mediated apoptosis promotes host survival 
we found that mice deficient in both RIPK3 and caspase-8, but not RIPK3 alone, had an 
acute survival defect, and succumbed within 4-5 days of oral infection with 
Y. pseudotuberculosis [75]. This survival defect correlated to increased bacterial burdens, 
but we were surprised to discover that these mice had a marked impairment in cytokine 
production [75]. We went on to show that caspase-8-deficient cells have a cell-intrinsic 
defect in cytokine production in vivo, and caspase-8 was required for maximal cytokine 
secretion in macrophages stimulated with multiple TLR ligands [75]. Surprisingly, 
Ripk3-/-Casp8-/- macrophages had consistent defects in the transcription of the pro-
inflammatory genes Il12b, Il1b, Il6 and Tnf among others [75].  
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Other groups have begun to identify a role for caspase-8 in inflammatory cytokine 
production as well. Ripk3-/-Casp8-/- mice have reduced IL-1β production during oral 
infection with the gram-negative enteric pathogen Citrobacter rodentium [110]. Caspase-
8 mediates pro-IL-1β expression during in vitro infection with Salmonella typhimurium 
[76], and mice infected with Yersinia pestis have defects in survival as well as 
inflammatory cytokine release [100]. The observed cytokine-regulatory role of caspase-8 
is not restricted to bacterial pathogens as pro-IL-1β expression is decreased in the absence 
of caspase-8 during in vitro infection with the fungal pathogen Candida albicans [147]. 
However, the mechanism of caspase-8-mediated cytokine production in response to TLR 
activation remains unclear. Caspase-8 is known to promote NF-κB-mediated pro-survival 
gene expression in response to TNFR stimulation at the plasma membrane [84, 107]. 
However, the mechanism by which caspase-8 interacts with and signals from TLRs has yet 
to be defined. TLR4 and TLR3 can signal through the adaptor protein TRIF which is known 
to signal to caspase-8 in response to TLR4 activation [107], However, we also identified a 
role for caspase-8 in response to MyD88-dependent TLRs such as TLR9, and there is no 
reported interaction between caspase-8 and MyD88. Moreover, it is unclear if caspase-8 
exerts it cytokine regulatory functions through the direct activation of NF-κB, indirect 
activation through a cytoplasmic intermediate, or another activation of transcription factor.  
To address these questions we first identified the repertoire of genes regulated by 
caspase-8, and used promoter enrichment analysis to identify common transcription factor 
binding motifs. We found that many of these motifs were annotated for NF-κB family 
members, and that there was specifically impaired recruitment of c-Rel to the promoters of 
caspase-8-dependent genes upon TLR4 stimulation in vitro. Moreover, c-Rel 
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overexpression was sufficient to restore expression of IL-12 and IL-1β in caspase-8-
deficient cells. We also demonstrated that caspase-8 exerts this function though differential 
IKK activation, and that the adaptor protein FADD was required for caspase-8-mediated 
cytokine production in response to both MyD88 and TRIF dependent TLRs. These studies 
provide insight into the divergent regulation of NF-κB proteins, and demonstrate an 
indirect role for caspsase-8-dependent regulation of NF-κB nuclear translocation.  
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2.3 Results 
2.3.1 Caspase-8 regulates hundreds of inflammatory genes in response to TLR stimulation 
that are enriched for NF-κB binding motifs.  
Caspase-8 deficient cells have defects in inflammatory gene transcription in 
response to both Myd88 and TRIF-dependent TLRs [75]. We sought to define the broad 
transcriptional program regulated by caspase-8 by measuring total RNA 2 and 6hrs post 
stimulation with the TLR4 and TLR9 agonists LPS and CpG respectively. We defined 
caspase-8 dependent genes as those that were differentially affected by the absence of 
caspase-8 (Fig 2.1A). Principle component analysis of our RNAseq data showed that 
samples segregated by the type of TLR ligand (PCA1) which accounted for 58% of the 
variance, and genotype was responsible for 8.8% of the variance (PCA2) (Fig 2.1B).We 
had observed a strong effect of caspase-8 on the transcription of Il12b and Il1b in response 
to LPS and CpG in previous in vitro experiments, but the repertoire of genes regulated by 
caspase-8 was much more extensive. Caspase-8 regulated 371 and 537 LPS inducible genes 
2 and 6 hours post stimulation respectively (Fig 2.1C). 388 and 316 CpG-inducible genes 
were regulated 2 and 6 hours post stimulation respectively (Fig 2.1C). LPS is known to 
induce approximately 2000 genes in macrophages [63]; therefore, in our hands, caspase-8 
regulates approximately 25% of all LPS-inducible genes after stimulation.  
Heat map analysis of caspase-8-dependent genes showed that many of these genes 
were downregulated in the absence of caspase-8 at both 2 and 6hrs post LPS and CpG 
stimulation (Fig 2.2A and Fig 2.2C). We performed gene ontology analysis (GO) with the 
genes identified in each data set, and identified three distinct clusters of genes that were 
caspase-8 dependent in both the LPS and CpG conditions. These clusters are highlighted 
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on the heat maps, and further characterized in panels 2.2B and 2.2D. There was a defect in 
the induction of immune-regulated genes in response to both LPS and CpG in the absence 
of caspase-8. Interestingly, there was also a defect in cell cycle gene expression in both 
data sets as well. We performed promoter analysis to identify common transcription factor 
binding motifs in the promoters of caspase-8-dependent genes at 6 hours post LPS and 
CpG stimulation. We identified significant enrichment for NF-κB binding motifs which 
was concordant with the GO analysis identifying cytokine and immune response genes in 
the data set (Fig 2.2E). This data suggested that we would see a defect in overall NF-κB 
signaling in caspase-8-deficient macrophages stimulated with both LPS and CpG.  
 
2.3.2 Caspase-8 promotes IKK phosphorylation in response to TLR stimulation. 
Upon TNFR stimulation caspase-8 indirectly regulates NF-κB signaling by cleaving the 
K63 deubiquitinase CYLD to promote stable ubiquitination of RIPK1 [133]. Ubiquitinated 
RIPK1 serves as a scaffold for IKKα, IKKβ, and IKKγ and mediates pro-survival gene 
expression in response to TNF signaling[106]. However, it is unclear if caspase-8 signals 
to NF-κB in response to TLR activation. Two kinases proximal to TLR stimulation are 
TAK1—induced in response to MyD88-dependent TLRs—and TBK—induced in response 
to TRIF-dependent TLRs. Using immunoblotting we were unable to identify any 
differences in phosphorylation of TAK1 in response to both LPS and CpG (Fig 2.3A) and 
TBK1 in response to LPS (Fig 2.3B). However, in caspase-8-deficient cells we consistently 
saw a defect in phosphorylation of IKKα/IKKβ which is downstream of TAK1 activation 
(Fig 2.3C). We observed enrichment for AP-1 family member transcription factor binding 
motifs in our gene promoter analysis (data not shown). However, we did not observe a role 
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for caspase-8 in MAPK activation measured through immunoblotting for phosphorylated 
p38 (Fig 2.3D). We did not test other members of the MAPK signaling cascade 
comprehensively, and this is a potential area of further investigation. From these data we 
concluded that caspase-8 positively regulates IKK phosphorylation after TAK1 activation, 
placing caspase-8 upstream of IKK phosphorylation and downstream of TAK1 
phosphorylation.  
 
2.3.3 Caspase-8 promotes IκBε degradation in response to TLR4 stimulation. 
NF-κB proteins are expressed in the cytoplasm as homo- and hetero-dimers [69]. 
IκB family members are bound to NF-κB proteins preventing their nuclear translocation 
until IκB proteins are phosphorylated and targeted for proteasomal degradation [175]. The 
observed requirement for caspase-8 in maximal IKKα/IKKβ phosphorylation suggested 
that caspase-8 would also indirectly regulate IκB protein degradation. We measured 
degradation of three IκB proteins (IκBα, IκBβ, and IκBε) in response to LPS and CpG. 
There was a slight, but consistent defect in IκBε degradation in response to LPS (Fig 2.4A 
and Fig 2.4B), and no defect in either IκBα or IκBβ (Fig 2.4A and Fig 2.4C). This was 
surprising given the profound defect we observed in IKKα/IKKβ phosphorylation in the 
absence of caspase-8. It is possible that IκBε is more sensitive to levels of phospho-IKK 
than other IκB proteins, or that the assays we used were not sensitive enough to measure 
small differences in degradation in the case of IκBα and IκBβ. The reported role for IκBε 
in the regulation of the NF-κB family members c-Rel and p65 [176] prompted us to 
investigate if there were measurable differences in nuclear translocation of these 
transcription factors in the absence of caspase-8.  
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2.3.4 Caspase-8 promotes c-Rel nuclear translocation in response to TLR4 and TLR9 
stimulation. 
Our previous observation that caspase-8 promoted IKK phosphorylation provoked 
the hypothesis that caspase-8 may exert its cytokine regulatory function through activation 
of the NF-κB family members c-Rel and p65. To test this hypothesis we used 
immunoblotting to measure the amount of c-Rel and p65 in nuclear enriched fractions of 
B6, Ripk3-/-, and Ripk3-/-Casp8-/- macrophages. We observed a defect in c-Rel translocation 
in response to both LPS and CpG—albeit slightly less so in response to CpG—and 
equivalent levels of p65 in nuclear fractions of B6 and Ripk3-/-Casp8-/- macrophages (Fig 
2.5A and Fig 2.5B). One possible interpretation of these data is that caspase-8 regulates 
overall c-Rel expression through its gene regulatory function, but we observed no 
difference in basal or inducible c-Rel levels in B6, Ripk3-/-, and Ripk3-/-Casp8-/- 
macrophages (Fig 2.5C). We then used confocal microscopy to directly quantify c-Rel 
nuclear translocation on a single-cell basis (Fig 2.5E). There was a consistent, and 
measurable defect in c-Rel translocation in Ripk3-/-Casp8-/- macrophages stimulated with 
both LPS and CpG (Fig 2.5D, Fig 2.5E, and Fig 2.5F). We consistently observed that CpG 
stimulation revealed a smaller defect than LPS stimulation, which can likely be attributed 
to the relative intensity of both stimuli. LPS stimulation appears to induce a larger and 
more rapid response in wild type macrophages when compared to CpG stimulation; 
therefore, the magnitude of the response to LPS stimulation creates a larger dynamic range 
in which we can observe the effect of caspase-8 on the maximal response to TLR stimuli. 
These data suggested that caspase-8 regulates inflammatory gene expression through the 
 33 
NF-κB family member c-Rel specifically. These data were surprising given that c-Rel is 
only reported to be required for Il12b expression in macrophages, and our transcriptional 
analysis implicated caspase-8 in the regulation of hundreds of LPS-and CpG-inducible 
genes. We next sought to determine if the defect in c-Rel translocation correlated with a 
measurable difference in recruitment to the promoters of caspase-8-depenent genes.  
 
2.3.5 Caspase-8 promotes c-Rel recruitment to the promoters of caspase-8-dependent 
genes.  
B6, Ripk3-/- and Ripk3-/-Casp8-/- macrophages have equivalent levels of p65 bound 
to the promoters of several caspase-8-dependent genes (Il12b, Il1b, Tnf, and Il6) after LPS 
stimulation (Fig 2.6A). These data are concordant with our observation that caspase-8 has 
no impact on p65 nuclear translocation in response to TLR4 stimulation. We did observe a 
defect in c-Rel recruitment to the promoters of Il12b, Il1b, Tnf, and Il6 after LPS 
stimulation (Fig 2.6A). Moreover, this defect occurred within 30 minutes LPS stimulation 
(Fig 2.6B). These data demonstrated that caspase-8 may mediate divergent regulation of 
p65 and c-Rel in response to TLR activation, as caspase-8 appears to be dispensable for 
p65 translocation, but not for c-Rel translocation. Given previous reports identifying a 
limited role for c-Rel in Il12b expression we next tested the requirement for c-Rel in 
transcription of other caspase-8-dependent genes.  
 
2.3.6 c-Rel regulates several caspase-8-dependent genes in response to TLR stimulation.  
Utilizing Rel-/-  macrophages we sought to assess the role for c-Rel in the regulation 
of caspase-8-dependent genes. The expression of several inflammatory genes in addition 
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to Il12b were decreased in Rel-/- macrophages stimulated with both LPS and CpG (Fig 
2.7A). This provided evidence that c-Rel was required for the expression of other 
inflammatory genes in addition to Il12b. We also observed a decrease in pro-IL-1β 
expression in the absence of c-Rel in response to both LPS and CpG which could be 
measured on a per cell basis (Fig 2.7B) as well using a bulk assay (Fig 2.7C). Surprisingly, 
we observed an increase in IL-6 secretion in Rel-/- macrophages stimulated with LPS 
despite the decrease we observed transcriptionally, and we observed no difference in TNF 
secretion between B6 and Rel-/- macrophages (Fig 2.7D). This suggested that although 
c-Rel regulates gene expression of several caspase-8-dependent genes there may be a 
threshold of transcript that is sufficient to mediate wild-type levels of cytokine secretion. 
There was a role for c-Rel in both the expression of Il1b and production of pro-IL-1β, 
which had not been previously identified. These data suggested that we could bypass the 
requirement for caspase-8 in IL-12p40 and pro-IL-1β production through the expression of 
c-Rel in caspase-8-deficient macrophages.  
 
2.3.7 c-Rel expression restores IL-12p40 and pro-IL-1β expression in caspase-8-deficient 
macrophages.  
We expressed c-Rel containing an IRES-GFP in macrophages lacking caspase-8. 
The inefficiency of this transfection created an internally controlled experiment by which 
we could measure the impact of c-Rel expression on a per-cell basis in cells expressing 
GFP compared to those that were GFP negative. Cells that are successfully transfected can 
be identified through GFP expression using flow cytometry (Fig 2.8A). After 6 hours the 
plasmid is expressed in approximately 30% of cells (Fig 2.8A and Fig 2.8B). We then used 
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intracellular cytokine staining with this mixed population of GFP+ and GFP- cells to 
determine if cell-intrinsic expression of c-Rel restored IL-12p40 and pro-IL-1β in 
individual cells. We found that expression of c-Rel restored IL-12p40 expression in 
Ripk3-/-Casp8-/- macrophages in the absence of stimulation as well as in response to LPS 
and CpG (Fig 2.9A). The expression of IL-12p40 in the absence of TLR activation may be 
due to the lack of co-expression of the negative regulator IκBε, meaning all plasmid-
derived c-Rel is able to translocate directly into the nucleus. Interestingly, only LPS 
stimulation coupled with c-Rel expression was sufficient to restore pro-IL-1β expression 
in the absence of caspase-8 (Fig 2.9B). These data suggest that another transcription factor 
synergizes with c-Rel to induce Il1b expression during CpG stimulation. It is also possible 
that a larger amount of c-Rel is required for induction of pro-IL-1β which is supported in 
part by the pronounced defect in pro-IL-1β in Rel-/- macrophages. The increase in IL-12p40 
and pro-IL-1β observed in Ripk3-/-Casp8-/- macrophages transfected with c-Rel was 
equivalent to expression observed in Ripk3-/- macrophages transfected with empty plasmid 
(Fig 2.10A and Fig 2.10B). This indicated that c-Rel expression in caspase-8-deficient 
cells was sufficient to restore IL-12p40 and pro-IL-1β expression to wild-type levels. These 
data collectively demonstrate that caspase-8 regulates Il12b and Il1b through the NF-κB 
family member c-Rel. This regulatory function seemed to be mediated indirectly through 
caspase-8-dependent activation of IKK. We next sought to define the adaptor proteins that 
coupled TLR activation to caspase-8. 
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2.3.8 Caspase-8 is coupled to TLR activation through the adaptor protein FADD.  
The adaptor protein FADD is known to promote recruitment of caspase-8 to TNFR 
[84] which led us to hypothesize that it might play a similar role in response to TLR 
activation. Single ablation of FADD leads to the induction of programed necrosis in 
response to macrophage stimulation, but these cells can be rescued when proteins required 
for programmed necrosis are also ablated [160]. Therefore, we tested the role of the adaptor 
protein FADD in promoting IKK activation in response to TLR4 and TLR9 stimulation 
using Fadd-/-Mlkl-/- macrophages which cannot undergo programmed necrosis. We 
observed a defect in IKKα/IKKβ phosphorylation in Fadd-/-Mlkl-/- macrophages in 
response to both LPS and CpG stimulation (Fig 2.11A and Fig 2.11B). FADD-deficiency 
also leads to a decrease in IκBε degradation in response to both LPS and CpG (Figure 
2.11C). Fadd-/-Mlkl-/- macrophages had a decrease in the transcription of Il12b, Il1b, and 
Il1a (Fig 2.11D) as well as the secretion of IL-12p40, TNF and IL-6 (Fig 2.11E). These 
data suggest that caspase-8 may be coupled to the activation of both MyD88 and TRIF 
dependent TLRs through FADD, although, the effects we observed in the absence of 
caspase-8 are even more stark in the absence of FADD. It is possible that FADD interacts 
with other signaling molecules that mediate inflammatory gene expression in addition to 
caspase-8. Moreover, these data are also preliminary as the experiments depicted in panels 
2.11C and 2.11D have only been performed once due to reagent limitations. However, the 
consistent impact of FADD on cytokine secretion and IKK phosphorylation suggests that 
this adaptor may be the mechanism by which caspase-8 is activated in response to TLR 
stimulation, although further studies are required.  
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2.4 Discussion  
Previous work has demonstrated a critical role for caspase-8 in apoptosis, 
programmed necrosis, and cytokine expression [76, 102, 105, 125]. Here we define a 
mechanism by which caspase-8 regulates Il1b and Il12b via the NF-κB family member c-
Rel (Fig 2.12). Caspase-8 promotes IKK phosphorylation which in turn induces IκBε 
degradation, c-Rel translocation, and c-Rel recruitment to the promoters of Il12b and Il1b. 
Despite our observation that caspase-8 regulates hundreds of LPS- and CpG-inducible 
genes, it appears that c-Rel is only required for expression of Il12b and Il1b. Therefore, 
there are likely other mechanisms of caspase-8-dependent inflammatory gene regulation 
that we have yet to identify. LPS and CpG promote expression of both overlapping, and 
distinct subsets, of caspase-8-depenent genes, suggesting that there is likely there is a 
common signaling mechanism for caspase-8 in response to both TLRs as well as TLR4 
and TLR9 specific regulation that is also caspase-8 dependent.  
Caspase-8-mediated c-Rel translocation appears to be specifically dependent on the 
sensitivity of IκBε to lower levels of IKK phosphorylation. Despite the strong decrease we 
observed in IKK phosphorylation, in the absence of caspase-8, IκBα and IκBβ degradation 
are indistinguishable from that observed in wild-type macrophages (Fig 2.4). There are 
studies demonstrating divergent temporal regulation of IκB proteins over the course of 
cellular activation [59], but it appears another mechanism of regulation may be differential 
sensitivity upstream kinases. The role of caspase-8 in the divergent regulation of p65 and 
c-Rel was also surprising. p65 and c-Rel are largely thought to be redundant during TLR 
activation in macrophages apart from the requirement for c-Rel in Il12b transcription [71]. 
However, our data suggest that c-Rel plays an important role in the expression of both 
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IL-12p40 and IL-1 family cytokines, offering a potential explanation for recent studies that 
have observed a role for caspase-8 in inflammasome priming via the induction of pro-IL-
1β [76, 77, 111].  
The mechanisms that govern disparate regulation of p65 and c-Rel in the cytoplasm 
have yet to be defined. Recent work has identified a novel cellular nucleic acid binding 
protein (CNBP) that is required for c-Rel translocation during TLR activation, but 
dispensable for p65 [24]. We did not observe a defect in CNBP enrichment in nuclear 
fractions of Ripk3-/-Casp8-/- macrophages (data not shown), but our data suggest that 
caspase-8 may be another cytoplasmic factor that bifurcates p65 and c-Rel activation. We 
observed that c-Rel expression was sufficient to restore IL-12p40 production to wild-type 
levels in untreated as well as LPS and CpG stimulated cells (Fig 2.9A and Fig 2.10A); 
however, only LPS stimulation restored pro-IL-1β production (Fig 2.9B). This was 
surprising given the defect in pro-IL-1β production in Rel-/- macrophages stimulated with 
both LPS and CpG (Fig 2.7B). It is possible that there was insufficient c-Rel to restore pro-
IL-1β production, or perhaps there is another regulatory factor that synergizes with c-Rel 
in this context.  
Our preliminary data suggest a role for the adaptor protein FADD in activation of 
caspase-8 in response to TLR stimulation. This data is intriguing given that FADD is 
known to collaborate with caspase-8 during activation of death receptors [89, 112, 177]. 
FADD appears to promote IKK phosphorylation in response to TRIF- and MyD88-
dependent TLRs which was surprising given recent work showing that MyD88 is 
dispensable for programed necrosis induced in response to TLR4 stimulation and caspase-
8 inhibition [107]. However, it is possible that MyD88 interacts directly with FADD in the 
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context of TLR signaling under pro-survival conditions. The protein structure of FADD 
may shed light on the mechanism of collaboration between TRIF, MyD88, caspase-8 and 
FADD. FADD contains a death effector domain which can recruit caspase-8 via homotypic 
interactions. TRIF contains a region annotated for “sufficient to induce apoptosis” 
suggesting this might promote an interaction with FADD. Finally, MyD88 contains a death 
domain that could mediate a direct interaction with the death domain of FADD. Therefore, 
FADD may facilitate caspase-8 recruitment downstream of death receptors as well as 
TLRs. However, more mechanistic investigations are required to define the role of FADD 
in caspase-8-mediated cytokine expression.  
In this chapter we have defined a mechanism for the regulation of Il12b and Il1b 
transcription by caspase-8. In Chapter 3 we will interrogate the role of caspase-8 
enzymatic activity in this system.  
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2.5 Figures 
 
 
 
Fig 2.1. Caspase-8 regulates hundreds of genes in response to TLR stimulation.  
(A) Diagram of RNAseq analysis experimental design. 
(B) Principal component analysis of transcriptional profiling data from untreated or 2hrs 
post-LPS- or CpG-treatment of B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs.  
(C) Total number of caspase-8-dependent genes at 2 and 6 hours post LPS or CpG 
stimulation. Venn diagrams demonstrating the overlap of caspase-8-dependent genes in 
both the LPS- and CpG-treated BMDMs. 
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Fig 2.2 Caspase-8 regulates inflammatory genes that are enriched for NF-κB binding 
motifs.  
(A, C) Heat maps of the global transcriptional response of B6, Ripk3-/-, and 
Ripk3-/-Casp8-/- BMDMs 2 or 6 hours post stimulation with either LPS (A) or CpG (C). 
Gene clusters containing caspase-8-dependent genes following LPS or CpG stimulation 
are numbered and indicated with a sidebar to the right of each heat map.  
(B, D) Bubble plot representation of gene ontology enrichment analyses on caspase-8-
dependent gene clusters shown in (A) and (C). Bubble color indicates the degree to which 
genes associated with each term were  upregulated (red) or downregulated (blue). Bubble 
size represents the number of genes within a cluster that were associated with each term. 
(E) HOMER gene promoter analysis of caspase-8-dependent genes 6 hours post LPS or 
CpG stimulation.  
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Fig 2.3 IKK phosphorylation is caspase-8-dependent in response to TLR stimulation.  
(A) Immunoblots of phospho-TAK1 and total TAK1 in B6, Ripk3-/-, and Ripk3-/-Casp8-/- 
BMDMs following stimulation with LPS or CpG for indicated times.  
(B) Immunoblots of phospho-TBK1 and total TBK1 in B6, Ripk3-/-, and Ripk3-/-Casp8-/- 
BMDMs following stimulation with LPS for indicated times.  
 (C) Immunoblots of phospho-IKKα/β and total IKKβ in B6, Ripk3-/-, and Ripk3-/-Casp8-/- 
BMDMs following stimulation with LPS or CpG for indicated times.  
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Fig 2.3 Continued: (D) Immunoblots of phospho-p38 and total p38 in B6, Ripk3-/-, and 
Ripk3-/-Casp8-/- BMDMs following stimulation with LPS or CpG for indicated times. 
 (A-B) Representative of two independent experiments. (C-D) Representative of three 
independent experiments.  
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Fig 2.4 TLR4-induced IκBε degradation is impaired in the absence of caspase-8.  
(A) Immunoblots of IkBε and IkBα in B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs stimulated 
with LPS or CpG.  
(B) Quantification of immunoblots of IkBε in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 
stimulated with LPS or CpG for 2hrs.   
(C) Immunoblots of IkBβ in B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs stimulated with 
LPS.  
Student’s two-tailed paired t-test, * p<0.05. Data are representative of at least three 
independent experiments. 
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Fig 2.5 Caspase-8 promotes c-Rel translocation independently of p65.  
(A) Immunoblots of c-Rel in nuclear fractions of Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 
following LPS or CpG stimulation for indicated times.  
(B) Immunoblots of p65 in nuclear fractions of B6, Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 
following LPS or CpG stimulation for indicated times.  
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Fig 2.5 Continued: (C) Total c-Rel expression in B6, Ripk3-/-, and Ripk3-/-Casp8-/- 
BMDMs stimulated with LPS or CpG for the indicated times. 
(D) Quantification of the ratio of mean fluorescence intensity of nuclear:cytoplasmic c-Rel 
in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs stimulated with LPS; box plots represent 60-150 
individual cells per condition, Box plots indicate the median, upper and lower quartiles, 
and upper and lower extremes of the data.  
(E) Quantification of the ratio of mean fluorescence intensity of nuclear:cytoplasmic c-Rel 
in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs stimulated with LPS or CpG; each datapoint 
indicates the mean of an individual experiment; Student’s two-tailed paired t-test, * p<0.05.  
(F) Representative confocal images of experiment quantified in (D, E); B6, Ripk3-/- and 
Ripk3-/-Casp8-/- BMDMs stimulated with LPS or CpG for 2hrs; c-Rel, actin and DAPI 
pseudo-colored in green, white and blue respectively.  
Student’s two-tailed unpaired t-test (n.s. not significant, **** p<0.0001). All data 
representative of at least three independent experiments. 
 
  
 48 
 
 
Fig 2.6 Caspase-8 promotes c-Rel recruitment to the promoters of caspase-8-dependent 
genes.  
(A) ChIP-qPCR measuring fold-enrichment of p65 and c-Rel at the promoters of Il12b, 
Il1b, Il6, and Tnf 2hrs post LPS stimulation.  
(B) Fold-enrichment of c-Rel at indicated cytokine gene promoters in Ripk3-/- and 
Ripk3-/-Casp8-/- BMDMs following LPS treatment was determined by ChIP-qPCR at 
indicated times post-stimulation. 
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01, *** p<0.001, 
**** p<0.0001). Error bars indicate ± SEM of triplicates. All data representative of at least 
three independent experiments. 
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Fig 2.7 c-Rel regulates both IL-12p40 and pro-IL-1β expression in response to TLR 
activation.  
(A) Fold-change in indicated inflammatory response genes in B6 and Rel-/- BMDMs 2hrs 
post-stimulation with LPS or CpG, as indicated.  
(B) Flow-cytometry quantification and (C) immunoblot of intracellular pro-IL-1β 
expression in B6 and Rel-/- BMDMs stimulated with LPS or CpG for 6hrs.  
 50 
Fig 2.7 Continued: (D) ELISA measurement of secreted IL-12p40, IL-6, and TNF in B6 
and Rel-/- BMDMs following stimulation with LPS or CpG for 6hrs.   
Student’s two-tailed unpaired t-test (n.s. not significant, ** p<0.01, *** p<0.001, **** 
p<0.0001). Error bars indicate ± SEM of triplicates. All data representative of at least three 
independent experiments. 
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Fig 2.8 hc-Rel-IRES-GFP is expressed robustly in primary macrophages.  
(A) Transfection schematic diagram indicating nucleofection of hc-Rel-IRES-GFP plasmid 
into primary BMDMs, and representative flow cytometry data indicating transfection 
efficiency measured 6hrs post-transfection.  
(B) GFP expression was assayed in B6, Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 6, 12 and 
24hrs post-transfection.  
Data are representative of three independent experiments. 
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Fig 2.9 hc-Rel expression restores both IL-12p40 and pro-IL-1β production in the absence 
of caspase-8.  
(A) Flow cytometry of intracellular IL-12p40 and (B) pro-IL-1β in Ripk3-/-Casp8-/- 
BMDMs transfected with an IRES-GFP-expressing empty vector or hc-Rel-IRES-GFP-
expressing plasmid and stimulated with LPS or CpG for 4hrs.  
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Fig 2.9 Continued: Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, *** 
p<0.001). Error bars indicate ± SEM of triplicates. All data representative of at least three 
independent experiments.   
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Fig 2.10 In the absence of caspase-8 hc-Rel expression restores both IL-12p40 and pro-IL-
1β to levels observed in Ripk3-/- cells.  
(A) Frequency of intracellular IL-12p40+ or (B) pro-IL-1β+ Ripk3-/- or Ripk3-/-Casp8-/- 
BMDMs transfected with hc-Rel-IRES-GFP-expressing plasmid and stimulated with LPS 
or CpG for 4hrs.  
Each data point represents the mean frequency of positive cells within an individual 
experiment. Lines link genotypes within the same experiment Student’s paired two-tailed 
t-test (n.s. not significant). 
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Fig 2.11 FADD promotes inflammatory gene expression and IKK phosphorylation in 
response to TLR activation.  
(A, B) Immunoblot of phospho-IKKα/β and total IKKβ in Mlkl-/- and Mlkl-/-Fadd-/- BMDMs 
stimulated with LPS (A) and CpG (B) for indicated times.  
(C) Immunoblots of IkBε in Mlkl-/- and Mlkl-/-Fadd-/- BMDMs stimulated with LPS or CpG 
for the indicated times. 
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Fig 2.11 Continued: (D) RT-qPCR of caspase-8-dependent genes in Mlkl-/- and 
Mlkl-/-Fadd-/- BMDMs stimulated with LPS or CpG for 2hrs.  
(E) ELISA of secreted IL-12p40, IL-6, and TNF in Mlkl-/- and Mlkl-/-Fadd-/-  BMDMs 
stimulated with LPS or CpG for 6hrs.  
Experiments representative of one (C, D) or two (A, B, E)  independent experiments. Error 
bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (n.s. not significant, 
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001).  
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Fig 2.12 Graphical abstract and future directions: Caspase-8 promotes Il12b and Il1b 
expression through c-Rel.   
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CHAPTER 3: Caspase-8 enzymatic activity promotes inflammatory 
gene expression in macrophages. 
3.1 Abstract  
Caspase-8 enzymatic activity is required for its apoptotic function and for the 
repression of programmed necrosis; however, it is unclear if this activity is required for its 
role in cell-intrinsic inflammatory gene expression. Others have shown that ablation of 
caspsase-8 expression impairs inflammatory gene expression and inflammasome priming. 
Data from our lab suggest a role for caspase-8 enzymatic activity in macrophage TLR 
activation, but others have found that caspase-8 scaffolding is sufficient to mediate gene 
expression in response to TRAIL stimulation. Using both genetic and chemical approaches 
we identify a role for both caspase-8 enzymatic and non-enzymatic activity in response to 
TLR activation. We show that caspase-8 is enzymatically active in response to both TLR4 
and TLR9 stimulation, and that inhibition of caspase-8 reduced the production of IL-12p40 
and IL-1β. We also demonstrate that caspase-8 enzymatic activity promotes IKK 
phosphorylation and c-Rel nuclear translocation—one mechanism that we have identified 
for caspase-8-mediated inflammatory gene regulation. These experiments demonstrate a 
role for the enzymatic activity of caspase-8 in inflammatory gene expression in response 
to TLR activation, adding to our understanding of the diverse functions of caspase-8 in 
macrophages.   
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3.2 Introduction 
Caspase-8 regulates two forms of cell death: apoptosis [102] and programmed 
necrosis [133]. In the context of apoptotic stimuli such as TNF or FasL caspase-8 is 
recruited to the death inducing signaling complexes (DISC) via its death effector domain 
[82, 85]. Apoptotic signals induce caspase-8 homodimerization, whereby each monomer 
undergoes auto-processing, and forms two catalytic sites that mediate cleavage of its 
apoptotic substrates [79, 80, 113]. Caspase-8 is also enzymatically active in heterodimers 
formed with a homologous protein cFLIP, as this enzymatic activity is required for the 
inhibition of programmed necrosis. Caspase-8 enzymatic activity under pro-survival and 
pro-apoptotic conditions is required for the cleavage of substrates that mediate 
programmed necrosis such as the K63 linear deubiquitinase CYLD [105]. It is 
hypothesized that caspase-8/cFLIP heterodimers are constitutively present under pro-
survival conditions, and that caspase-8 monomers do not form stable catalytic sites without 
the presence of cFLIP [105]. Under pro-survival conditions caspase-8/cFLIP heterodimers 
mediate cleavage of CYLD, this cleavage promotes ubiquitination of RIPK1 (Receptor 
Interacting Serine/Threonine Kinase 1) which serves as a scaffold for the recruitment of 
IKKγ, and activation of NF-κB proteins to promote transcription of pro-survival genes 
[106]. Chemical or pathogen mediated blockade of NF-κB signaling leads to the down-
regulation of cFLIP expression and induction of apoptosis [178-180]. 
Our group as well as other have demonstrated another role for caspase-8 in the cell-
intrinsic expression of inflammatory cytokines [75, 77, 100]; however, the role of caspase-
8 enzymatic activity in this context has yet to be resolved. We have demonstrated that both 
chemical inhibitors of caspase-8 catalytic activity and inhibition of cFLIP expression 
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impairs cytokine secretion in macrophages stimulated with TLR agonists [75]. These data 
support a model in which caspase-8 enzymatic activity mediates inflammatory gene 
expression. However, work from others has shown that caspase-8 scaffolding is sufficient 
to induce NF-κB activation in response to TRAIL (Tumor necrosis factor related apoptosis 
inducing ligand) stimulation in HeLa cells [112]. These models are not mutually exclusive 
as it is possible that there are cell-specific and stimuli-specific functions of caspase-8.  
We utilized two approaches in an effort to elucidate the function of caspase-8 
enzymatic activity in the context of gene expression. The first being chemical inhibition of 
caspase-8 catalytic activity in Ripk3-/- macrophages as well as macrophages derived from 
mice in which we ablated caspase-8-dependent apoptosis, but preserved its cytokine 
regulatory function. These mice express caspase-8 with a mutation in the linker region that 
mediates stabilization of the apoptotic conformation of caspase-8 [80, 113]. We refer to 
these mice, and cells derived from them, as Casp8DA/DA. Our characterizations of these mice 
will be described in Chapter 4: briefly, macrophages from these mice are unable to 
undergo caspase-8 dependent apoptosis in response to Yersinia pseudotuberculosis (Yp) 
infection, but secrete wild-type levels of inflammatory cytokines in response to TLR 
stimulation [75]. We have crossed these mice with Ripk3-/- mice to eliminate the impact of 
programmed necrosis in this system: we refer to mice, and cells derived from them ,as 
Ripk3-/-Casp8DA/DA. In this chapter we seek to elucidate the role of the pro-survival 
conformation of caspase-8 on inflammatory gene expression as well as the enzymatic 
requirements for this function.  
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3.3. Results 
3.3.1 TLR stimulation promotes caspase-8 catalytic activity.  
We have previously shown that inhibition of caspase-8 catalytic activity reduced 
inflammatory cytokine secretion, but it is possible that this was mediated by off-target 
effects of these chemical compounds [75]. Therefore, we sought to directly test the 
activation of caspase-8 in response to TLR stimulation. Previous groups have shown that 
TLR4 stimulation promotes the cleavage of the linear deubiquitinase CYLD [107]. We 
found that caspase-8 catalytic activity was induced in response to both LPS and CpG in 
Ripk3-/- macrophages within 30 min of stimulation (Fig 3.1A). Interestingly, this activation 
was not to the same magnitude as that observed with the apoptotic stimulus staurosporine 
(Fig 3.1A). All caspase-8 activation was blocked by the pan-caspase inhibitor zVAD; 
therefore, we concluded that our previous findings demonstrating a role for caspase-8 in 
inflammatory cytokine secretion were likely not due to off target effects of zVAD 
(Fig 3.1A). We also found that CYLD was cleaved in response to LPS stimulation, and 
that this cleavage was partially blocked using both zVAD and the caspase-8-specific 
inhibitor IETD (Fig 3.1B). These data demonstrate that caspase-8 activity is induced in 
response to TLR activation, and that chemical inhibition—using zVAD or IETD—is 
sufficient to block a majority of caspase-8 activity. 
 
3.3.2 Caspase-8 enzymatic activity promotes inflammatory gene expression and IKK 
phosphorylation.  
We measured transcription of several caspase-8-dependent genes (described in 
Chapter 2) in Ripk3-/- macrophages stimulated with the TLR4 and TLR9 agonists LPS and 
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CpG respectively. zVAD inhibition reduced expression of Il12b in response to LPS but not 
CpG (Fig 3.2A). This result was surprising given the defect we observed in IL-12p40 
secretion in LPS- and CpG-stimulated Ripk3-/- macrophages treated with zVAD (Fig 3.2B). 
Moreover, zVAD treatment was not sufficient to decrease LPS-induced Il12b transcription 
to the same magnitude as ablation of caspase-8, but it appears this was sufficient to reduce 
IL-12p40 secretion to similar levels observed in Ripk3-/-Casp8-/- macrophages (Fig 3.2A 
and Fig 3.2B). These data suggest that there is a threshold of Il12b transcript required for 
secretion of IL-12p40, and the decrease we observed in the context of zVAD inhibition is 
sufficient to reduce cytokine secretion to levels observed in Ripk3-/-Casp8-/- macrophages. 
There was a similar trend in the expression of Il1b in LPS-stimulated cells: zVAD 
treatment impaired transcription, and this reduction was sufficient to reduce pro-IL-1β 
expression to levels observed in Ripk3-/-Casp8-/- macrophages (Fig 3.2A and Fig 3.2B). We 
measured a decrease in transcription of Il1a and Il4i1 in LPS-stimulated Ripk3-/- 
macrophages treated with zVAD, but again this decrease was not to the same magnitude 
as caspase-8 ablation. There was no role for caspase-enzymatic activity in the transcription 
of Il1a or Il4i1 in response to CpG  which is consistent with what we observed for Il12b 
and Il1b (Fig 3.2A).  
We interpret these data to mean that both caspase-8 enzymatic activity and 
scaffolding play a role in inflammatory gene expression, but the role of each appears to be 
gene and TLR-dependent. There seems to be more of a requirement for caspase-8 
enzymatic activity in response to TLR4 stimulation, but it seems to be dispensable in some 
contexts in response to CpG. Based on these data we expected to observe a role for caspase-
8 enzymatic activity in the phosphorylation of IKK in response to LPS, and not CpG, but 
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we were surprised to find zVAD treatment reduced IKK phosphorylation in both contexts 
(Fig 3.2C). It is possible that NF-κB-dependent genes display differing levels of sensitivity 
to IKK phosphorylation as we do not see a defect in transcription of Il12b, Il1a, and Il4i1 
in CpG-stimulated macrophages treated with zVAD (Fig 3.2A). One possible explanation 
is that the use of a pan-caspase inhibitor masked caspase-8-specific enzymatic 
requirements; therefore, we sought to test the impact of the caspase-8-specific inhibitor 
IETD on gene transcription. 
 
3.3.3 Caspase-8 enzymatic activity promotes Il12b transcription and IL-12p40 secretion. 
Consistent with our previous observations, Ripk3-/- macrophages treated with IETD 
have decreased IL-12p40 secretion in response to LPS (Fig 3.3A). We also discovered this 
was the case in response to CpG stimulation, again, suggesting a role for caspase-8 
enzymatic activity in IL-12 secretion in response to both LPS and CpG (Fig 3.3A). 
Surprisingly, IETD reduced Il12b transcription in response to both LPS and CpG to the 
same magnitude as that observed in Ripk3-/-Casp8-/- macrophages (Fig 3.3B). We interpret 
these data to mean that caspase-8 enzymatic activity is required for transcription of Il12b, 
and corresponding secretion of IL-12p40 in response to TLR activation. It is possible that 
because zVAD targets other caspases it is not sufficient to block all caspase-8 activity, but 
we could observe no measurable caspase-8 activity in our previous assay in Ripk3-/- 
macrophages treated with zVAD (Fig 3.1A). Based on our observations that caspase-8 
catalytic activity mediated inflammatory gene expression and IKK phosphorylation we 
hypothesized that we would observe a decrease in c-Rel nuclear translocation in zVAD-
treated cells (based on findings discussed in Chapter 2).  
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3.3.4 Caspase-8 enzymatic activity promotes c-Rel nuclear translocation. 
We quantified nuclear translocation of c-Rel using single-cell analysis of Ripk3-/- 
macrophages treated with zVAD then stimulated with LPS or CpG. Consistent with the 
observed role for caspase-8 enzymatic activity on gene expression, zVAD treatment 
reduced c-Rel translocation (Fig 3.4B).. However, this reduction was not to the same 
magnitude as that observed in observed in Ripk3-/-Casp8-/- macrophages (Fig 3.4B). 
Ripk3-/- macrophages treated with zVAD have much less nuclear c-Rel when compared to 
vehicle-treated cells stimulated with LPS or CpG. We interpret these data to mean that 
caspase-8 enzymatic activity promotes c-Rel translocation in response to both TLR4 and 
TLR9 agonists, but caspase-8 scaffolding also contributes to c-Rel translocation in this 
context. We next sought to determine if enzymatically inactive caspase-8 recapitulated our 
observations with Ripk3-/- macrophages treated with chemical inhibitors of caspase-8 
activity.  
 
3.3.5 Caspase-8 enzymatic activity promotes cytokine secretion.   
We transduced wild-type caspase-8 (Casp8WT), catalytically inactive caspase-8 
(Casp8D3A), and an empty vector into Ripk3-/-Casp8-/- immortalized macrophages 
(Fig 3.5A). Each construct also expressed GFP allowing us to enrich for transduced cells 
after puromycin selection, resulting in an approximately 95% pure population (data not 
shown). We observed that cells expressing catalytically inactive caspase-8 had reduced 
secretion of TNF in response to both LPS and CpG; however, not to the magnitude 
observed in our empty vector controls expressing no caspase-8 (Fig 3.5B). These data are 
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consistent with our observations in primary Ripk3-/- macrophages treated with zVAD in 
which there are enzymatic and non-enzymatic contributions of caspase-8. One question 
raised by these data was whether some low-level of caspase-8 homodimers contribute to 
the observed requirement for caspase-8 enzymatic activity without causing measurable cell 
death.  
 
3.3.6 Caspase-8 non-apoptotic activity mediates inflammatory cytokine expression and 
IKK phosphorylation.  
It is hypothesized that caspase-8 homodimers do not form under pro-survival 
conditions, but it is formally possible that both caspase-8/cFLIP heterodimers and 
caspase-8 homodimers are present in Ripk3-/- macrophages under these conditions. To 
address this question we utilized macrophages in which caspase-8 apoptotic activity is 
inactive, but the protein is expressed and maintains catalytic activity (Casp8DA/DA). 
Casp8DA/DA macrophages expressed Il12b to the same extent as B6 macrophages stimulated 
with LPS (Fig 3.6A). IKK phosphorylation in Casp8DA/DA macrophages was 
indistinguishable from B6 macrophages stimulated with LPS (Fig 3.6B). These data were 
consistent with our previous report that Casp8DA/DA macrophages produced cytokines to the 
same magnitude as B6 cells [75]. We have previously found no role for RIPK3 in gene 
expression, but we generated macrophages from Ripk3-/-Casp8DA/DA to formally test the 
role for programed necrosis in this context. Surprisingly, we found that LPS-stimulated 
Ripk3-/-Casp8DA/DA macrophages expressed Il12b to a higher magnitude than Ripk3-/-Casp8-
/- cells, but not to the same extent as Ripk3-/- cells (Fig 3.6C). This was concordant with the 
intermediate level of IKK phosphorylation observed in Ripk3-/-Casp8DA/DA macrophages 
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stimulated with LPS (Fig 3.6E). However, Ripk3-/-Casp8DA/DA macrophages secreted IL-
12p40 equivalently to Ripk3-/- macrophages in response to LPS stimulation (Fig 3.6D). 
These data are similar to our previous observations that defects in cytokine gene 
transcription cannot be directly correlated to cytokine protein secretion. It is possible that 
despite the observed reduction in Il12b transcription, in Ripk3-/-Casp8DA/DA macrophages 
stimulated with LPS, there was enough transcript to mediate wild-type levels of IL-12p40 
secretion.  
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3.4 Discussion 
Here we describe a role for caspase-8 enzymatic activity in inflammatory gene 
transcription in macrophages. Moreover, we were able to directly measure catalytic activity 
of caspase-8 in response to the Myd88-dependent TLR9. This was surprising given that 
there is limited data suggesting that caspase-8 can be activated downstream of MyD88. In 
support of a model in which MyD88 activates caspase-8, we observed defects in IKK 
phosphorylation, and c-Rel translocation in response to CpG stimulation (discussed in 
Chapter 2), and here we report that this defect is in part due to the absence of caspase-8 
catalytic activity. We also report for the first time that there is a defect in inflammatory 
cytokine secretion when caspase-8 catalytic activity is blocked in CpG-stimulated cells. 
The role for caspase-8 enzymatic activity is less clear with regards to CpG-induced gene 
transcription, as we cannot observe a decrease in transcription of Il12b, Il1b, Il1a, or Il4i1 
in zVAD-treated cells.  
This is surprising given our observation that zVAD treatment blocks IKK 
phosphorylation as well as IL-12p40 and pro-IL-1β production to levels observed in 
Ripk3-/-Casp8-/- macrophages in response to CpG stimulation. It is not likely that zVAD 
incompletely inhibits caspase-8 catalytic activity as we can detect no activity in response 
to LPS, CpG, or staurosporine in zVAD-treated cells (Fig 3.1A). However, the caspase-8-
specific inhibitor IETD completely abrogates transcription of Il12b in response to both LPS 
and CpG. Therefore, it is possible that there is some latent caspase-8 activity in 
zVAD-treated cells that we cannot detect with our caspase-8-activity assay.  
 We also observed a partial block of c-Rel translocation in macrophages treated with 
zVAD, and we interpret these data to mean that both caspase-8 scaffolding and enzymatic 
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activity contribute to c-Rel translocation in response to LPS and CpG stimulation. These 
data are consistent with the observed dual contributions of caspase-8 enzymatic activity 
and scaffolding in gene transcription in response to LPS; however, it appears that this 
partial block is sufficient to inhibit cytokine secretion to levels observed in Ripk3-/-Casp8-/- 
macrophages. It is clear from these data that cytokine secretion does not reflect gene 
transcription with enough fidelity for cytokine secretion to serve as a proxy for the levels 
of mRNA induced in response to TLR stimuli. These data also suggest that there is a 
threshold of transcript required in macrophages to mediate wild-type levels of cytokine 
secretion. If this is indeed the case, then caspase-8 enzymatic activity is critical for the 
purposes of cytokine secretion in macrophages, and its inhibition is sufficient to mimic 
complete ablation of caspase-8. 
 Our data demonstrated that immortalized Ripk3-/-Casp8-/- macrophages transduced 
with catalytically inactive caspase-8 have intermediate levels of cytokine secretion, 
suggesting some contribution of caspase-8 scaffolding in this context.  One caveat to these 
data are that immortalized macrophages secrete fewer cytokines than primary cells, and 
Ripk3-/-Casp8-/- macrophages transduced with wild-type caspase-8 have no detectable 
IL-12p40 as measured by ELISA or flow-cytometry (data not shown). TNF is the only 
cytokine that is measurable in these cultures; therefore, it is possible that if we were able 
to generate primary cells expressing catalytically inactive caspase-8 we would observe a 
requirement for its activity in IL-12 secretion, as we see in chemically inhibited primary 
cells. However, this is entirely speculative given the technical limitations of this 
experiment.  
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 We also reported a surprising role for RIPK3 in the context of a mutant form of 
caspase-8 that is unable to mediate apoptosis. Ripk3-/-Casp8DA/DA macrophages had 
intermediate levels of IKK phosphorylation and gene expression when compared to Ripk3-/- 
and Ripk3-/-Casp8-/- macrophages (Fig 3.6C and Fig 3.6E), whereas Casp8DA/DA 
macrophages phenocopied B6 macrophages stimulated with LPS (Fig 3.6A and Fig 3.6B). 
This suggests that RIPK3 promotes stabilization of the catalytic site of Casp8DA/DA. This is 
surprising given that caspase-8 and RIPK3 are reported to exist in distinct complexes [105, 
108]. However, RIPK3 is reported to be a substrate of caspase-8 [111] and other groups 
have implicated RIPK3 indirectly in apoptosis and [126] inflammasome activation [127]. 
Therefore, it is possible that RIPK1, RIPK3, cFLIP, FADD, TRADD, and caspase-8 
interact more dynamically than is assumed in the Complex I, Complex II and necrosome 
transition model of different forms of cell death. It is likely that a combination of signals 
bias cells towards preferential interactions between these proteins, RIPK3/RIPK1 in the 
context of programed necrosis, RIPK1/caspase-8 in apoptosis, and RIPK1/cFLIP/caspase-
8 under pro-survival conditions. Our data suggest that in response to TLR stimulation 
RIPK3 promotes the inflammatory gene regulatory function of Casp8DA/DA, perhaps via 
stabilization of its catalytic site.  
 To our knowledge these studies represent the first report of caspase-8 activity in 
response to TLR9 activation. We also demonstrate a role for caspase-8 enzymatic activity 
in IKK phosphorylation, c-Rel translocation, and Il12b and Il1b transcription in response 
to both LPS and CpG (Fig 3.7).  These data support a model in which caspase-8 enzymatic 
activity is a key component of inflammatory gene expression in response to multiple TLRs.   
 70 
3.5 Figures 
 
Fig 3.1 TLR stimulation promotes caspase-8 catalytic activity. 
(A) IETDase activity (arbitrary fluorescence units) in Ripk3-/- BMDMs 3.5hrs post  
staurosporine treatment or 30min post LPS or CpG stimulation in the presence or absence 
of zVAD, as indicated.  
(B) CYLD cleavage in Ripk3-/- BMDMs 4hrs post LPS stimulation was measured by 
immunoblotting cell lysates for CYLD in cells pre-treated with zVAD, IETD or vehicle 
control as indicated 1hr prior to stimulation. 
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01, 
**** p<0.0001). (A) is from an individual experiment and (B) is representative of three 
independent experiments.  
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Fig 3.2 Caspase-8 enzymatic activity regulates activation of the IKK complex.  
(A) Fold-change in mRNA expression of indicated genes in Ripk3-/- and Ripk3-/-Casp8-/- 
BMDMs pre-treated with zVAD or vehicle control for 1hr followed by treatment with LPS 
or CpG for 2hrs.  
(B) Levels of secreted IL-12p40, measured by ELISA, and frequency of intracellular 
pro-IL-1β expression, measured by flow cytometry, by Ripk3-/- and Ripk3-/-Casp8-/- 
BMDMs pre-treated with zVAD or vehicle control for 1hr followed by LPS or CpG 
treatment for 5hrs. 
(C) Immunoblots of phospho-IKKα/β and total IKKβ in Ripk3-/- BMDMs pre-treated with 
zVAD or vehicle control for 1hr and stimulated with LPS or CpG for the indicated times. 
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (n.s. not 
significant, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). All data representative of 
three independent experiments. 
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Fig 3.3 Caspase-8 enzymatic activity mediates Il12b expression in response to TLR 
activation. 
(A) Secreted IL-12p40 assayed by ELISA in supernatants of Ripk3-/- BMDMs pre-treated 
with IETD or vehicle control (DMSO) for 1hr followed by 5hr stimulation with LPS or 
CpG.  
(B) Fold change in Il12b expression in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs pre-treated 
with IETD or vehicle control for 1hr prior to 2hrsof LPS or CpG treatment. 
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01, 
*** p<0.001, **** p<0.0001). Data are representative of two  independent experiments.  
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Fig 3.4 Caspase-8 enzymatic activity contributes to c-Rel nuclear translocation in response 
to TLR signaling.  
(A) Representative confocal microscopy images of Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 
pre-treated with zVAD or vehicle control for 1hr followed by LPS or CpG stimulation as 
indicated for 2hrs; c-Rel, actin and DAPI pseudo-colored in green, white and blue 
respectively.  
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Fig 3.4 Continued: (B) Quantification of the mean fluorescence intensity of 
nuclear:cytoplasmic c-Rel in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs pre-treated with zVAD 
or vehicle control for 1hr prior to LPS or CpG treatment for 2hrs.   
Box plots represent 60-150 individual cells per condition. Student’s two-tailed unpaired 
t-test (n.s. not significant, * p<0.05, ** p<0.01, **** p<0.0001). Box plots illustrate the 
median, upper and lower quartiles, and upper and lower extremes of the data. All data 
representative of at least three independent experiments. 
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Fig 3.5 Caspase-8 enzymatic activity and scaffolding promote inflammatory cytokine 
secretion.  
(A) Depiction of the caspase-8 constructs transduced into Ripk3-/-Casp8-/- iBMDMs. 
(B-C) ELISA measurement of secreted TNF in Ripk3-/-Casp8-/- iBMDMs transduced with 
WT caspase 8 (Casp8WT), catalytically inactive caspase 8 (Casp8D3A), or an empty vector 
and stimulated with LPS or CpG as indicated for 12hrs.  
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01, 
*** p<0.001, **** p<0.0001). Data are representative of two independent experiments. 
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Fig 3.6 Non-cleavable caspase-8 promotes inflammatory gene expression and IKK 
phosphorylation in response to TLR stimulation.  
(A) Fold-change in Il12b expression in B6 and Casp8DA/DA BMDMs stimulated with LPS 
for 2hrs. 
(B) Immunoblots of phospho-IKKα/β and total IKKβ in B6 and Casp8DA/DA BMDMs 
stimulated with LPS for the indicated times.  
(C) Fold-change in Il12b expression in Ripk3-/- , Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA 
BMDMs stimulated with LPS for 2hrs.  
(D) Secreted IL-12p40 assayed by ELISA in supernatants of B6, Casp8DA/DA, Ripk3-/- , 
Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA BMDMs stimulated with LPS for 6hrs.  
(E) Immunoblots of phospho-IKKα/β and total IKKβ from Ripk3-/-, Ripk3-/-Casp8-/-, and 
Ripk3-/-Casp8DA/DA BMDMs after LPS stimulation for indicated times.  
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Fig 3.6 Continued: Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired 
t-test (n.s. not significant, ** p<0.01, *** p<0.001, **** p<0.0001). Data are representative 
of three independent experiments.  
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Fig 3.7 Graphical abstract and future directions: Caspase-8 enzymatic activity and 
scaffolding mediate inflammatory gene expression. 
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CHAPTER 4: Selective ablation of caspase-8 apoptotic activity protects 
thymocytes from Fas-mediated cell death and leads to the accumulation 
of myeloid cells. 
4.1 Abstract 
Two critical functions of caspase-8-mediated apoptosis are the clearance of 
autoreactive cells as well as pathogen-infected cells. Caspase-8-mediated apoptosis is 
induced upon activation of tumor necrosis factor receptor superfamily members; this 
family includes Fas/CD95 and TNFR1/2. Upon activation of these receptors by their 
cognate ligands FADD is recruited to the death domain of the cytoplasmic portion of these 
transmembrane proteins, and FADD in turn recruits caspase-8 via homotypic interactions 
between their death effector domains. Upon recruitment caspase-8 monomers undergo 
auto-processing through cleavage of the linker region between the p10 and p20 subunits of 
each monomer. This auto-processing stabilizes two catalytic sites in the caspase-8 
homodimer which mediate the cleavage of the apoptotic substrate BID (BH3-interacting 
domain death agonist). Caspase-8 also negatively regulates another form of cell death: 
programmed necrosis. In the absence of caspase-8 programmed necrosis is de-repressed 
mediating embryonic lethality. Dual ablation of caspase-8 and the proteins that mediate 
programmed necrosis—MLKL and RIPK3—rescues these mice from embryonic lethality. 
Ripk3-/-Casp8-/- mice display a lymphoproliferative disease that is characterized by 
splenomegaly, lymphadenopathy, and the accumulation of CD3+B220+ cells that begins 
6-weeks postnatally. These characteristics are attributed to both a defect in programmed 
necrosis and apoptosis, which prevents homeostatic turnover of circulating lymphocytes in 
these mice. We sought to determine if specific ablation of caspase-8 apoptotic activity 
recapitulated the observations made in Ripk3-/-Casp8-/- mice. We generated mice with a 
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non-cleavable linker sequence between the p10 and p20 subunit of the caspase-8 monomer 
referred to as Casp8DA/DA mice, and crossed these mice to RIPK3-deficient mice to generate 
Ripk3-/-Casp8DA/DA mice. We were surprised to find that these mice display a unique 
lymphoproliferative disease, distinct from Ripk3-/-Casp8-/- mice, that is characterized by 
the accumulation of innate immune cell populations. These data suggest that caspsase-8 
apoptotic activity is dispensable for lymphocyte homeostasis, but required for maintenance 
of normal myeloid cell numbers.  
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4.2 Introduction 
Caspase-8 plays a critical role in host survival through the clearance of autoreactive 
cells [181], tumorigenic cells [182], and infected cells [183]. It is thought that caspase-8 
mediates these functions through caspase-8-dependent apoptosis activated in response to a 
variety of cell death stimuli. Broadly, death signals such as FasL (Tumor necrosis factor 
ligand superfamily member 6) or TNF (Tumor necrosis factor) bind to their cognate 
receptors which belong to the tumor necrosis receptor superfamily. Upon receptor 
activation the adaptor proteins FADD [168] (Fas-associated death domain protein) and 
TRADD [84] (Tumor necrosis factor receptor type 1-associated death domain protein) are 
recruited to the cytoplasmic domain of the transmembrane death receptor via their death 
domains (DD). TRADD and FADD indirectly or directly mediate recruitment of caspase-8 
[184] forming the death inducing signaling complex (DISC). Under death inducing 
conditions caspase-8 monomers oligomerize [85], and undergo auto-processing which 
stabilizes their apoptotic activity [79]. Patients with non-functional caspase-8 display a 
lymphoproliferative disease [157] that is similar to disease displayed in patients with 
mutations in the death receptor Fas [165] as well as its cognate ligand FasL [185]. Studies 
elucidating the role caspase-8 in lymphocyte homeostasis in vivo were historically difficult 
as single ablation of caspase-8 results in embryonic lethality. However, in 2011 two groups 
demonstrated that dual ablation of caspase-8 and RIPK3 (Receptor-interacting 
serine/threonine-protein kinase 3), which mediates another cell death pathway known as 
program necrosis, resulted in viable progeny [104, 105]. These groups implicated 
caspase-8 in the negative regulation of programmed necrosis during development as well 
as during cellular activation [104, 105]. 
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Mice in which both RIPK3 and caspase-8 are ablated display lymphoproliferative 
disease that resembles the phenotype of mice with Fas or FasL mutations: lpr and gld mice 
respectively [105, 186]. Lymphoaccumulation in Ripk3-/-Casp8-/- mice begins 6 weeks 
postnatally, and is characterized by splenomegaly, lymphadenopathy, and accumulation of 
CD3+B220+CD8-CD4- cells [105]. RIPK3-deficient mice do not display 
lymphoproliferative disease, which suggests that caspase-8-dependent apoptosis promotes 
clearance of circulating lymphocytes as mice age. These data were not entirely surprising 
given that Fas-mediated cell death is important for regulating autoreactive T cells [187] as 
well as total numbers of naïve T cells in the periphery [188].  
In addition to its role in cell death caspase-8 has been implicated in the regulation 
of inflammatory gene expression. However, in vivo these studies were performed using 
Ripk3-/-Casp8-/- mice which display a defect in caspase-8-dependent apoptosis as well as 
gene expression [75, 77, 110] during infection. In an effort to separate the gene-regulatory 
function of caspase-8 from its apoptotic function we generated mice in which the apoptotic 
confirmation of caspase-8 is rendered unstable. The apoptotic confirmation of caspase-8 is 
stabilized in part through auto-processing of the linker sequence between its p10 and p20 
subunits [79, 80]. Therefore, we generated a mouse in which this sequence is mutated 
which we will refer to as Casp8DA/DA [75]. We have previously demonstrated that cells 
derived from these mice are able to produce inflammatory cytokines in response to the 
TLR4 agonist LPS, but do not undergo apoptosis when infected with the gram-negative 
bacterial pathogen Yersinia pseudotuberculosis—a potent activator of caspase-8-mediated 
apoptosis [75]. To further elucidate the role of caspase-8-mediated gene regulation in host 
defense in vivo we generated Ripk3-/-Casp8DA/DA mice in which caspase-8-dependent 
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apoptosis and RIPK3-dependent programmed necrosis are ablated (Fig 4.1). In this chapter 
we discuss both our preliminary characterizations of these mice, and our discovery that 
caspase-8-dependent apoptosis may play a novel role in regulating myeloid cell 
populations in naïve mice.  
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4.3 Results  
4.3.1 Ripk3-/-Casp8DA/DA mice display a lymphoproliferative disease that is divergent from 
that of Ripk3-/-Casp8-/- mice. 
Previous studies have identified a role for caspase-8 in preventing splenomegaly 
and lymphadenopathy [104, 105], which has been attributed to caspase-8-mediated 
apoptosis in response to Fas stimulation. These mice are completely protected from Fas-
mediated apoptosis leading to the accumulation of a CD3+B220+CD4-CD8- cell population 
in the periphery [105]. In an effort to isolate the role of caspase-8-mediated inflammatory 
cytokine expression from its role in apoptosis we generated a mouse in which 
caspase-8-dependent apoptosis and RIPK3-mediated programed necrosis are ablated, but 
the cytokine regulatory function of caspase-8 is preserved (Fig 4.1). These mice will be 
referred to as Ripk3-/-Casp8DA/DA. We anticipated that these mice would display the same 
lymphoproliferative disease observed in Ripk3-/-Casp8-/- mice, and Ripk3-/-Casp8DA/DA mice 
do exhibit splenomegaly similar to Ripk3-/-Casp8-/- mice (Fig 4.2A and Fig 4.2B). 
However, unlike mice in which caspase-8 is ablated there is no observable 
lymphadenopathy in Ripk3-/-Casp8DA/DA mice (Fig 4.2C). Moreover, in Ripk3-/-Casp8DA/DA 
mice we could not detect the CD3+B220+CD4-CD8- T cell population that characterizes 
Ripk3-/-Casp8-/- mice (Fig 4.3A and Fig 4.3B). These data were surprising given that the 
accumulation of this cell population is what mediates splenomegaly and lymphadenopathy 
in Ripk3-/-Casp8-/- mice; therefore, we then took a histological approach to asses immune 
cell populations in the spleens of Ripk3-/-Casp8DA/DA mice.  
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4.3.2 Ablation of capsase-8 apoptotic activity mediates splenomegaly that is characterized 
by both myeloid and lymphocyte infiltration.  
Histological analysis of the spleens of Ripk3-/-Casp8DA/DA mice revealed large 
disruptions in the overall splenic architecture (Fig 4.4) characterized by atypical 
lymphocyte expansion in the white pulp, lymphoid atrophy, and severe extramedullary 
erythropoiesis. This disruption in splenic architecture is not present in Ripk3-/-Casp8-/- 
mice. Staining for immune populations (CD3+ T cell, CD45+ total immune cells, and 
F4/80+ monocytes/macrophage) also showed a divergent cellular infiltrate phenotype in 
the spleens of Ripk3-/-Casp8DA/DA mice when compared to those of Ripk3-/-Casp8-/- mice. 
Ripk3-/-Casp8DA/DA mice had CD3+ cells that expanded into the while pulp compressing the 
remaining follicles, whereas follicular architecture was persevered in the Ripk3-/-Casp8-/- 
mice and lymphocyte proliferation was restricted to the marginal zone (Fig 4.4). 
Surprisingly, Ripk3-/-Casp8DA/DA mice had robust infiltration of macrophages and 
monocytes in both the white and red pulp of the spleen (Fig 4.4). These data implicated 
myeloid cells as well as CD3+ lymphocytes in the observed splenomegaly in 
Ripk3-/-Casp8DA/DA mice. We then sought to characterize  differences in circulating cell 
populations as well as those in secondary lymphoid structures that did not display 
differences in total organ weight or cellularity.  
 
4.3.3 Ablation of the apoptotic activity of caspase-8 correlates with innate immune 
population expansion in secondary lymphoid organs.  
Previous groups have described a population CD3+B220+ cells that mediates the 
lymphadenopathy in Ripk3-/-Casp8-/- mice [104, 105]. However, Ripk3-/-Casp8DA/DA mice 
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do not have this population suggesting that there is a clear divergence between the 
phenotypes of Ripk3-/-Casp8DA/DA and Ripk3-/-Casp8-/- mice. Therefore, we characterized 
Ripk3-/-Casp8DA/DA mice in comparison with Ripk3-/- controls, and observed that 
Ripk3-/-Casp8DA/DA mice had no observable lymphadenopathy and even displayed a trend 
to overall lower cell counts in their mesenteric lymph nodes (mLNs) (Fig 4.2C and Fig 
4.5A). In the mLNs we observed a decrease in overall CD8+ T cells with a trend towards 
lower CD4+ T cell numbers (Fig 4.5B and Fig 4.6A). In the blood there was also a trend 
towards an increase in CD8-CD4-CD3+ cells which is concordant with our histological 
observations in the spleen (Fig 4.5C). There was a large increase in total numbers of 
monocytes/macrophages and neutrophils in the mLNs of Ripk3-/-Casp8DA/DA mice when 
compared to Ripk3-/- mice (Fig 4.5D, Fig 4.5E and Fig 4.6B). These data suggested that 
caspase-8 apoptotic activity is required for maintenance of homeostatic levels of myeloid 
populations in secondary lymphoid organs. However, it is unclear why the expansion of 
myeloid cells was not observed in Ripk3-/-Casp8-/- mice [105]. The other group describing 
these mice observed no differences in frequencies of neutrophils and monocytes in the 
lymph node that they analyzed [104]; however, they do not state which lymph node they 
isolated, and they did not calculate total cell numbers. Data that we will discuss in Chapter 
6 suggest that Ripk3-/-Casp8-/- mice do not have increased numbers of  myeloid cells in the 
context of bacterial infection. The observed decrease in CD8+ T cells in the mLNs of 
Ripk3-/-Casp8DA/DA mice prompted us to investigate if these mice had any defects in thymic 
development.  
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4.3.4 Caspase-8 apoptosis is dispensable for T cell development in the thymus. 
 The observed accumulation of CD3+CD4-CD8- cells in the spleen as well as the 
decrease in overall CD8+ T cell numbers suggested a defect in the transition of DN to DP 
cells in the thymus. However, we were unable to observe any differences between 
Ripk3-/-Casp8DA/DA  and Ripk3-/- mice in progression from DN to DP nor in positive 
selection of CD4+ and CD8+ single positive cells expressing TCRβ (Fig 4.7A). Moreover 
we could not observe any difference in thymic weights or cellularity between 
Ripk3-/-Casp8DA/DA  and Ripk3-/- mice (Fig 4.7B and Fig 4.7C). We then measured the 
sensitivity of DP and single positive thymocytes to Fas stimulation with the expectation 
that they should be protected due to the ablation of caspase-8 apoptotic activity. However, 
we were surprised to find that only DP and CD4+ thymocytes from Ripk3-/-Casp8DA/DA mice 
were protected from Fas-dependent apoptosis (Fig 4.7E and Fig 4.7F). CD8+ cells were 
not protected from Fas-dependent apoptosis, which could explain why we observed less 
overall CD8+ cells in the mLNs of Ripk3-/-Casp8DA/DA mice (Fig 4.5B and Fig 4.7D). These 
data were unexpected as complete ablation of caspase-8 protects thymocytes from 
Fas-dependent apoptosis, but the group that reported this phenotype only performed this 
analysis on bulk thymocytes [105] of which DP cells are the majority of the total 
population. We found that these cells have no defect in caspase-9-mediated apoptosis—
cell death induced by the caspase-8/9 agonist staurosporine was more robust in 
Ripk3-/-Casp8DA/DA single positive thymocytes (Fig 4.7D, Fig 4.7E and Fig 4.7F). Overall 
these data suggest that the non-apoptotic conformation of caspase-8 is sufficient to 
mediated Fas-dependent cell death in CD8+ thymocytes, but not in CD4+ or DP cells.  
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4.4 Discussion 
Given the recent evidence that caspase-8 mediates cell death as well as 
inflammatory gene expression [75, 77, 110] we sought to specifically evaluate the 
contribution of caspase-8-dependent cytokine production to host defense in vivo. 
Caspase-8 apoptotic activity is stabilized through the auto-processing of a linker sequence 
between the p10 and p20 subunit of each caspase-8 monomer [79, 80]. We generated a 
mouse in which the residue that is required for this cleavage is mutated (D387A) [80] 
preventing auto-processing, and destabilizing the apoptotic conformation of caspase-8. We 
have previously demonstrated that macrophages derived from these mice are protected 
from caspase-8-dependent apoptosis, but produce inflammatory cytokines when stimulated 
with LPS [75]. These mice were further crossed onto Ripk3-/- mice to generate a line that 
was deficient for caspase-8-mediated apoptosis and RIPK3-dependent programmed 
necrosis, but sufficient for the cytokine regulatory function of caspase-8. These mice were 
generated in an effort to directly compare mice in which caspase-8 is completely ablated—
which must be done on a RIPK3-deficient background—to mice expressing the 
conformation of caspase-8 that mediates inflammatory cytokine expression. We performed 
initial characterizations of the progeny of these crosses with the expectation that their 
phenotype would largely recapitulate that of Ripk3-/-Casp8-/- mice. While there were 
superficial similarities between these mice, such as splenomegaly, there were pronounced 
differences in immune cell populations between each line.  
Ripk3-/-Casp8DA/DA display splenomegaly characterized by a disruption in splenic 
architecture (Fig 4.4). The reasons for this disruption are not clear as caspase-8-dependent 
apoptosis is known to play a role in overall embryonic development, but to our knowledge 
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no one has implicated this function in the development of germinal centers in the spleen. 
RIPK3 is dispensable for development of these structures as Ripk3-/- mice have no 
histological defects in their splenic architecture (Fig 4.4). Furthermore, a defect in 
apoptosis is not sufficient to explain the aberrant splenic architecture in Ripk3-/-Casp8DA/DA 
mice as Ripk3-/-Casp8-/- mice do not have this phenotype. It is possible that this disruption 
is not due to a defect in development per se, but rather due to myeloid and CD3+ 
lymphocyte infiltrate into the while pulp of the spleens isolated from Ripk3-/-Casp8DA/DA 
mice;  however, this explanation is entirely speculative.  
 The observed accumulation of myeloid cells in the mLNs of Ripk3-/-Casp8DA/DA 
mice was surprising given that Ripk3-/-Casp8-/- mice are not reported to display this type of 
cellular accumulation. One potential explanation is that because caspase-8 promotes the 
secretion of chemokines (Chapter 2) there is sufficient recruitment of myeloid cells from 
the bone marrow, but because apoptosis is impaired there is a defect in clearance under 
steady-state conditions. Neutrophils in particular have a very short circulating half-life 
(5-6hrs) [189]; therefore, caspase-8 apoptotic activity might play a critical role in control 
of neutrophil numbers. These data, while interesting, also require further mechanistic 
investigation to define the role of caspase-8-mediated apoptosis in monocyte and 
neutrophil turnover.  
 The most notable hallmark of the lymphoproliferative disease seen in 
Ripk3-/-Casp8-/- mice is their accumulation of CD3+B220+CD4-CD8- lymphocytes—this 
phenotype largely mimics observations in lpr and gld mice which have defects in the genes 
encoding Fas and FasL respectively [105, 186]. Interestingly, we observed an accumulation 
of CD3+ cells in the spleens of Ripk3-/-Casp8DA/DA mice as well as a trend towards 
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accumulation in the blood, but these cells do not express B220+; suggesting they are an 
alternative population of double negative T cells. We hypothesized that this accumulation 
was due to a defect in thymic development leading to an increase in the circulation of 
double negative cells in the periphery, but our characterizations of thymic cellularity, 
thymic weight, and T cell development revealed no differences between Ripk3-/-Casp8DA/DA 
and Ripk3-/- mice (Fig 4.7). More comprehensive analysis is required to determine what 
lymphocyte population these cells belong to, and whether these cells mediate the 
splenomegaly we observed in  Ripk3-/-Casp8DA/DA mice. More intriguingly, if this 
population of CD3+CD4-CD8-B220- cells is limited by caspase-8-dependent apoptosis then 
these data implicate caspase-8 in the regulation of a novel cell population under steady-
state conditions.  
Overall, these data demonstrate a specific role for caspase-8-mediated apoptosis in 
maintenance of myeloid and CD3+ lymphocyte populations in naïve mice; however, 
non-cleavable caspase-8 appears to be sufficient to prevent the accumulation of 
CD3+B220+CD4-CD8- cells in the periphery. The expression of non-cleavable caspase-8 is 
also sufficient to mediate Fas-dependent apoptosis in CD8+ thymocytes, but not in double 
positive or CD4+ populations. In Chapter 3 we demonstrated that Ripk3-/-Casp8DA/DA and 
Ripk3-/- macrophages secrete cytokines to the same magnitude when stimulated with the 
TLR4 agonist LPS. We also observed that the cytokine regulatory function of caspase-8 is 
partially dependent on its enzymatic activity, which suggests that non-cleavable caspase-8 
is enzymatically active in this context. It is possible that in CD8+ cells the non-cleavable 
conformation of caspase-8 is sufficient to mediate Fas-induced apoptosis, which would 
reflect novel differences in caspase-8 enzymatic and structural requirements for the 
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induction of cell death in naïve T cell populations. In Chapters 5 and 6 we explore the role 
non-cleavable caspase-8 plays in host defense in vivo.  
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4.5 Figures 
 
Fig 4.1 RIPK3-null Casp8DA/DA mice are expected to be deficient in cell death pathways. 
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Fig 4.2 Ablation of capsase-8 apoptotic activity mediates splenomegaly.  
(A) Images of spleens isolated from 16-week-old female littermates (Ripk3-/-, 
Ripk3-/-Casp8DA/DA, Ripk3-/-Casp8DA/+ and Ripk3-/-Casp8-/-). 
(B) Weights of spleens isolated from 16-week-old female mice (Ripk3-/-, 
Ripk3-/-Casp8DA/DA, Ripk3-/-Casp8DA/+, and Ripk3-/-Casp8-/-; n=3-7 per mouse). 
(C) Weights of mLNs isolated from 16-week-old female mice (Ripk3-/-, Ripk3-/-Casp8DA/DA, 
and Ripk3-/-Casp8-/-; n=3-4 except Ripk3-/-Casp8-/- n=1). 
Student’s two-tailed unpaired t-test (n.s. not significant, *** p<0.001). Error bars indicate 
± SEM. Pooled data from two different experiments. 
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Fig 4.3 Non-cleavable capsase-8 protects mice from CD3+B220+ cell accumulation. 
(A) Total numbers of live Lin-CD90+CD3+CD4-CD8-B220+ lymphocytes isolated from the 
blood of 16 week old female littermates (Ripk3-/-, Ripk3-/-Casp8DA/DA, and Ripk3-/-Casp8-/- 
; n=3 except Ripk3-/-Casp8-/- n=1). 
(B) Total numbers of live Lin-CD3+CD4-CD8-B220+ lymphocytes isolated from the 
spleens of 16-week-old female littermates (Ripk3-/-, Ripk3-/-Casp8DA/DA, and Ripk3-/-Casp8-
/-; n=3 except Ripk3-/-Casp8-/- n=1). 
Student’s two-tailed unpaired t-test (n.s. not significant). Error bars indicate ± SEM. All 
data representative of two independent experiments. Lineage markers (CD19 and NK1.1) 
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Fig 4.4 RIPK3-null Casp8DA/DA mice have disrupted splenic architecture and increased 
immune cell infiltrate.  
Representative images from H&E, CD3, CD45 and F4/80 stained spleen paraffin sections 
prepared by the Children’s Hospital of Philadelphia Pathology Core. Analysis of sections 
performed by Penn Veterinary Medicine Pathology Core (Ripk3-/- n=6, Ripk3-/-Casp8DA/DA 
n=7, Ripk3-/-Casp8-/- n=2). 
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Fig 4.5 RIPK3-null Casp8DA/DA mice have expanded populations of myeloid cells in 
secondary lymphoid organs.  
(A) Total cell numbers in mLNs isolated from Ripk3-/- and  Ripk3-/-Casp8DA/DA mice (n=3).  
(B) Live+CD3+ lymphocytes isolated from the mLNs of Ripk3-/- and Ripk3-/-Casp8DA/DA 
mice (n=3).  
(C) Live+CD90+CD3+CD4-CD8- lymphocytes in the blood of Ripk3-/- and 
Ripk3-/-Casp8DA/DA mice (n=3).  
(D) Live+CD3-CD19-CD45+F4/80+ cells isolated from the mLNs of Ripk3-/- and 
Ripk3-/-Casp8DA/DA mice (n=3).  
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Fig 4.5 continued: (D) Live+CD3-CD19-CD45+Ly6G+Ly6C+ cells isolated from the mLNs 
of Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3).  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01). Error bars 
indicate ± SEM. All data representative of two independent experiments. 
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Fig 4.6 Representative gating strategy for the characterization of both innate and adaptive 
immune populations in RIPK3-null Casp8DA/DA mice. 
(A). Flow contour plot showing gating strategy for classification of CD4+, CD8+ and DN 
T cells isolated from the mLN of a Ripk3-/- mouse. 
(B). Flow contour plot showing gating strategy for classification of innate immune cell 
populations isolated from the mLN of a Ripk3-/- mouse.  
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Fig 4.7 RIPK3-null Casp8DA/DA mice have normal T cell development and are partially 
protected from Fas-dependent apoptosis.  
(A) Total numbers of DN, DP and single positive thymocytes isolated from Ripk3-/- and 
Ripk3-/-Casp8DA/DA mice (n=3-4). Cells gated on live, singlets that were lineage negative. 
Lineage markers (CD11b, CD11c, CD19, CD49, and Gr-1).  
(B). Total weights of thymi isolated from Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3-4). 
(C). Total cell counts of thymi isolated from Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3-4). 
(D-E). Frequency of Annexin V+7AAD+ CD8+, CD4+ and DP thymocytes isolated from 
Ripk3-/- and Ripk3-/-Casp8DA/DA and stimulated with the indicated concentrations of FasL 
(with 25μg/mL cycloheximide) for 24hrs or 10μM staurosporine for 8hrs. (n=3-4 
mice/group).  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01, 
*** p<0.001). Error bars indicate ± SEM. All data representative of two independent 
experiments. 
  
 101 
CHAPTER 5: Caspase-8 promotes host survival during acute 
Toxoplasma gondii infection. 
5.1 Abstract  
Caspase-8 has been recently implicated in the regulation of inflammatory gene 
expression. Caspase-8-dependent cytokine secretion has been shown to mediate host 
defense in response to gram-negative bacterial pathogens in vivo; however, it is unclear if 
this function is required in other contexts. Il12b expression as well as the secretion of 
IL-12p40 are significantly impaired in macrophages lacking caspase-8. IL-12p40 serves as 
a subunit of both IL-23 and IL-12p70, two cytokines known to be important for host 
survival during infection with a variety of pathogens. IL-12p70 is specifically critical for 
the control of acute infection with the obligate, intracellular parasite Toxoplasma gondii. 
T. gondii belongs to the Apicomplexa phylum which contains other pathogens such as 
Plasmodium and Cryptosporidium parvum. T. gondii infects mammals through food or 
water contaminated with cysts excreted in cat feces leading to a significant amount of 
foodborne illness in the United States annually. C57BL/6 mice survive infection with the 
attenuated strain of T. gondii (Prunigard), and this survival is dependent on the secretion 
of IL-12p70 by dendritic cells. We show that caspase-8-deficient mice have an acute 
survival defect that largely recapitulates the observed phenotype in IL-12p40-deficient 
mice. Moreover, this defect is characterized by lower levels of IL-12p40 production by 
caspase-8-deficient dendritic cells, and impaired monocyte recruitment into the peritoneum 
of infected animals. Caspase-8-deficient animals can be rescued through exogenous 
injection of IL-12p70, leading to parasite clearance, and recruitment of inflammatory 
monocytes. To our knowledge these are the first studies implicating caspase-8-mediated 
cytokine secretion in host survival against a eukaryotic pathogen.   
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5.2 Introduction 
Caspase-8 plays a cell-intrinsic role in inflammatory cytokine secretion in vitro and 
in vivo during infection with the gram-negative bacterial pathogen Yersinia 
pseudotuberculosis [75]. Others have demonstrated a role for caspase-8 in cytokine 
secretion during infection with another gram-negative enteric pathogen Citrobacter 
rodentium [110]. However, to our knowledge no one has tested the role for caspase-8 in 
survival during infection with a eukaryotic pathogen. Toxoplasma gondii is endemic to the 
United States, and causes a significant percentage of domestic foodborne illness cases 
annually [136]. Most carriers are asymptomatic, but pregnant women and 
immunocompromised individuals are at significant risk for life-threatening complications 
associated with toxoplasmosis [135]. C57BL/6 mice largely survive acute infection with 
the attenuated Prunigard strain of T.gondii, and this survival is dependent on the production 
of IL-12 [137], and Il12b-/- mice rapidly succumb to acute T. gondii infection [138].  
The primary source of IL-12 during T. gondii infection is thought to be from 
uninfected inflammatory monocytes and conventional dendritic cells that detect T. gondii 
antigen [139]. Detection of T. gondii by dendritic cells is mediated in part by TLR11 and 
TLR12 upon recognition of profilin [190]. Secreted IL-12 then induces IFNγ production 
by NK cells in addition to cytotoxic CD8 and CD4 T cells; IFNγ promotes killing of 
infected cells through cell-extrinsic and cell-intrinsic mechanisms [140, 142, 191-193]. 
Interestingly, T. gondii actively suppresses apoptosis; therefore, the primary mechanism of 
clearance is T-cell-mediated killing or induction of intracellular reactive oxygen species in 
infected cells [142, 144, 145, 194]. Cytokine secretion is particularly important in this 
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context as it is required for the recruitment of T cells as well as paracrine signaling from 
bystander cells to infected cells.  
We have shown that caspase-8-deficient macrophages have a defect in the 
expression of Il12b and secretion of IL-12p40 (Chapter 2). Moreover, in vivo there is a 
cell-intrinsic defect in IL-12p40 production in caspase-8-deficient monocytes and 
neutrophils during gram-negative bacterial infection [75]. These data provoked the 
hypothesis that caspase-8 may play a role in host defense during T. gondii infection via its 
cytokine regulatory function, specifically through the expression of IL-12. Although 
caspase-8 mediates both cell death and inflammatory cytokine expression, host defense 
during T. gondii infection is largely dependent on cytokine production by responding innate 
immune cells. Therefore, we hypothesized that caspase-8-mediated cell death would be 
dispensable for host survival during T. gondii infection.   
We utilized two models to interrogate the role of caspase-8 in host defense against 
T. gondii: one in which caspase-8 was completely ablated, and one in which caspase-8-
apoptotic activity was disrupted while preserving its cytokine regulatory function. We 
found a requirement for caspase-8 in host survival during T. gondii infection that was 
indistinguishable from the requirement for IL-12. Moreover, caspase-8-deficient animals 
had a defect in IL-12p40 production by dendritic cells, and survival of these mice could be 
completely rescued through the exogenous injection of IL-12p70. To our knowledge these 
data are the first to demonstrate a role for caspase-8 in host survival during infection with 
an intracellular, eukaryotic pathogen via the cytokine regulatory function of caspase-8. 
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5.3 Results 
5.3.1 Caspase-8-deficient animals are acutely susceptible to T. gondii infection. 
IL-12-deficient animals have a pronounced survival defect during intraperitoneal 
infection with a low dose (10,000 tachyzoites) of an attenuated strain of T. gondii 
(Prunigard, Pru). We observed a role for caspase-8 in the induction of Il12b in 
macrophages, but Il12b expression and IL-12p40 secretion are not completely abrogated 
in this context. Therefore, we were surprised to find that Ripk3-/-Casp8-/- mice were just as 
susceptible to T. gondii infection as Il12b-/- mice (Fig 5.1A). Ripk3-/-Casp8-/- mice had 
parasite burdens that were statistically indistinguishable from Il12b-/- mice suggesting that 
caspase-8 mediates host survival through control of parasite replication (Fig 5.1C). 
Cytospins of peritoneal exudate cells (PECs) also show that Il12b-/- and Ripk3-/-Casp8-/- 
mice have similar numbers of parasites per cell (Fig 5.1B and Fig 5.1D). Dendritic cells 
(DCs) in the PECs of infected Ripk3-/-Casp8-/- mice had impaired production of IL-12p40 
(Fig 5.2A). Representative flow plots show the gating strategy for identifying Lin-
CD64-CD11c+MHCII+ DCs as well as representative IL-12p40 staining in DCs from the 
PECs of B6, Ripk3-/-, Ripk3-/-Casp8-/-, and Il12b-/- mice 5 days post infection (Fig 5.2B and 
Fig 5.2C). As dendritic cells are the primary mediators of IL-12p40 production during T. 
gondii infection these data suggest that impaired survival of caspase-8-deficient animals 
was due to failure to induce sufficient IL-12p40. Interestingly, IL-12p40 production by 
DCs in Ripk3-/-Casp8-/- mice was not completely abrogated, but this amount of cytokine 
production appeared to be below the threshold required to mediate host survival.  
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5.3.2 IL-12 rescues caspase-8-deficient animals during acute T. gondii infection. 
 We hypothesized that exogenous IL-12 would restore host survival in caspase-8-
deficient animals by compensating for the observed defect in IL-12 production by DCs. As 
expected IL-12 injections rescued Il12b-/- mice, and were also sufficient to completely 
rescue  Ripk3-/-Casp8-/- mice (Fig 5.3A). Moreover, IL-12 treatment reduced parasite 
burdens in Ripk3-/-Casp8-/- mice to levels observed in B6 and Ripk3-/- mice (Fig 5.3B and 
Fig 5.3C). Another mechanism of parasite control is through infiltration of inflammatory 
monocytes that promote parasite killing [195]. We observed a defect in recruitment of 
inflammatory monocytes by total cell number as well as frequency into the peritoneum of 
caspase-8-deficient animals (Fig 5.3D and Fig 5.3E). Interestingly, this impaired 
recruitment was very similar to that observed in Il12b-/- mice, again suggesting that a 
threshold of IL-12 production is required to mount an innate response to T. gondii infection. 
We were also able to restore infiltration of inflammatory monocytes with the injection of 
exogenous IL-12. While these data are correlative they suggest that caspase-8-dependent 
IL-12 secretion mediates host defense during T. gondii infection.  
 
5.3.3 IL-12 rescues c-Rel-deficient animals during acute T. gondii infection. 
 We have previously shown that in macrophages caspase-8 promotes Il12b 
expression in part through the transcription factor c-Rel (Chapter 2). Previous groups have 
shown that c-Rel-dependent IL-12 is important for the adaptive response in an oral model 
of  T. gondii [196]. However, to our knowledge no one has investigated the contribution of 
c-Rel to intraperitoneal infection with T. gondii tachyzoites. We found that Rel-/- animals 
succumbed with similar kinetics to Il12b-/- animals, and that these mice were completely 
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rescued by exogenous IL-12 (Fig 5.4). We interpret these data to mean that c-Rel dependent 
IL-12 may also be protective in the intraperitoneal infection model of T. gondii, implicating 
caspase-8 in the c-Rel/IL-12 axis in this system.  
 
5.3.4 Expression of non-cleavable caspase-8 reduced host mortality during acute T. gondii 
infection.  
 Although there is no reported role for caspase-8-dependent apoptosis in host 
defense during T. gondii infection—this pathway is repressed in T.gondii-infected cells—
it was formally possible that caspase-8-dependent apoptosis contributes to survival. To 
specifically test the contribution of caspase-8-mediated inflammatory cytokine secretion 
during T. gondii infection we utilized a mouse model in which caspase-dependent apoptosis 
and RIPK3-mediated programmed necrosis are ablated while preserving caspase-8-
cytokine secretion (Ripk3-/-Casp8DA/DA). Ripk3-/-Casp8DA/DA mice had reduced mortality 
during T. gondii infection; however, not to the same magnitude as Ripk3-/- mice (Fig 5.5A). 
There was also considerable variance in the percentage of infected PECs isolated from 
Ripk3-/-Casp8DA/DA mice 5 days post infection suggesting that some mice fail to control 
replication while others are able to (Fig 5.5B). These data implicated caspase-8-apoptotic 
activity in host defense; however, mice that are sufficient for RIPK3, but also express non-
cleavable caspase-8 have no detectible parasites in their PECs 5 days post infection 
(Fig 5.5C). One possible explanation for this observation is that RIPK3 may be required 
to help stabilize the non-cleavable conformation of caspase-8 in dendritic cells during in 
vivo infection with T. gondii. This would be surprising given that we can find no role for 
RIPK3 in protection against T. gondii: Ripk3-/- mice have identical parasite burdens when 
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compared to B6 mice (Fig 5.1C). However, these data are preliminary as the experiments 
in panel B and C were only performed once. More experiments are required to determine 
if there is a synergistic effect between RIPK3 and non-cleavable caspase-8 during T. gondii 
infection.   
 
5.3.5 Ablation of caspase-8 in hematopoietic cells results in increased parasite burdens and 
a defect in monocyte infiltration.  
 The observed decrease in IL-12 secretion from caspase-8-deficient DCs suggested 
that caspase-8-mediated cytokine production in the immune compartment was the primary 
mechanism that promoted host survival during acute T. gondii infection. To test this 
hypothesis we generated bone marrow chimeras in which B6 mice were sublethally 
irradiated, and reconstituted with bone marrow from B6, Ripk3-/-, Ripk3-/-Casp8-/-, and 
Il12b-/- mice. These mice had parasite burdens that were concordant with our observations 
in mice lacking Ripk3-/-Casp8-/- or Il12b-/- in both the hematopoietic and non-hematopoietic 
compartments, suggesting that control of parasite burdens is largely mediated by caspase-8 
in immune cells (Fig 5.6A). B6 mice with caspase-8 deficiency in their hematopoietic 
compartment also have impaired monocyte recruitment into their peritoneum 5 days post 
infection, providing additional evidence that this infiltration is mediated by caspase-8 
expression in immune cells (Fig 5.6B). These data demonstrate a role for caspase-8 
expression in hematopoietic cells during acute T. gondii infection.  
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5.4 Discussion  
 To our knowledge these data implicate the cytokine regulatory function of 
caspase-8 in host defense during T. gondii infection for the first time (Fig 5.7). The defect 
in IL-12 production by caspase-8-deficient DCs suggests a broad role for caspase-8 in 
cytokine production in a variety of innate immune cell populations in vivo. The observed 
contribution of c-Rel to host survival provokes the hypothesis that the TLR/caspase-8/c-
Rel axis may promote cytokine secretion by DCs as well as macrophages (Fig 5.8). We 
have not tested the in vitro requirement for caspase-8 in IL-12 production by DCs infected 
with T. gondii or stimulated with the T. gondii antigen STAg (soluble tachyzoite antigen), 
but it is possible that we would observe a defect in IL-12 production in this context as well. 
These data also demonstrate the principle of thresholding in the immune response 
to inflammatory mediators. It appears that there is a threshold of IL-12 required for mice 
to mount an early innate response to T. gondii. Unlike Il12b-/- mice, caspase-8-deficient 
animals have some IL-12 production, but this amount of IL-12 is not sufficient to promote 
control of parasite replication or recruitment of inflammatory monocytes into the 
peritoneum of infected animals. These data are similar to our observations in which 
caspase-8 expression in immune cells is required for maximal production of cytokines 
during infection with Yersinia pseudotuberculosis [75]. However, the role of caspase-8 in 
IL-12 production during T. gondii infection remains correlative. Mice with cDC-specific 
depletion [197] would enable us to generate mixed bone marrow chimeras with bone 
marrow from mice lacking cDCs and bone marrow from mice lacking caspase-8. This will 
allow us to directly test the cell-intrinsic role of caspase-8, in cDCs in vivo, during T. gondii 
infection.  
 109 
Given the requirement for caspase-8 in protection against an obligate, intracellular, 
eukaryotic pathogen it would be interesting to test its role in control of another member of 
the Apicomplexa phylum: Cryptosporidium parvum. Recent advances have made it 
possible to culture C. parvum in vitro and inoculate mice with a rodent-adapted strain of 
the parasite [198]. Very little is known about C. parvum-mediated antagonism of the host 
immune response or the mechanisms of host control; therefore, investigations into the 
possible role for caspase-8 in this model may provide insight into host-pathogen 
interactions during C. parvum infection in vivo.  
In these studies we also demonstrated a role for caspase-8-dependent cytokine 
production separate from caspase-8-dependent apoptosis during T. gondii infection. 
However, on a RIPK3-null background expression of non-cleavable caspase-8 was not 
sufficient to mediate survival of all infected animals. We also observed significant 
variability in parasite burdens from PECs isolated from Ripk3-/-Casp8DA/DA mice 5 days 
post infection. From experiments discussed in Chapter 4 we know that Ripk3-/-Casp8DA/DA 
mice have a defect in total numbers of CD8 T cells in their secondary lymphoid organs. 
CD8 T cells are critical for host defense against T. gondii, and can be recruited into the 
peritoneum very rapidly post infection [191]. Therefore, it is possible that the intermediate 
survival phenotype observed in Ripk3-/-Casp8DA/DA mice could be attributed to a defect in 
cytotoxic CD8 T cell recruitment into the peritoneum after infection, and not due to 
impaired caspase-8-dependent apoptosis. We did not measure IFNγ production by NK cells 
or adaptive cell populations in any of the experiments we conducted, nor did we test the 
effector functions of these populations. These outstanding questions provide opportunities 
for future studies to determine if the observed defect in IL-12 production correlates with 
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impaired IFNγ production or impaired effector responses during T. gondii infection of 
caspase-8-deficient mice. Collectively, the data described here provide evidence for the 
broad protective role played by caspase-8 in response to infection, and the specific 
contribution of caspase-8-mediated cytokine expression to host defense during infection 
with a eukaryotic pathogen.  
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5.5 Figures 
 
Fig 5.1 Caspase-8 promotes survival during acute T. gondii infection.  
(A) Survival of B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice (n=5-10) infected 
intraperitoneally with T.gondii.  
(B) Representative cytospins of infected cells in the PECs of T.gondii-infected B6, Il12b-/, 
Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post-infection.  
(C) Quantification of infected cell frequency and (D) parasites per cell in the PECs of 
T. gondii-infected B6, Il12-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post-infection; each 
data point represents a single mouse.  
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test 
(** p<0.01, *** p<0.001). (C) and (D) Student’s two-tailed unpaired t-test  
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Fig 5.1 Continued: (n.s. not significant, ** p<0.01, **** p<0.0001).  Error bars indicate 
± SEM. Data representative of three independent experiments. 
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Fig 5.2. Caspase-8 promotes IL-12 production by DCs during acute T. gondii infection. 
(A) Frequency of IL-12p40+ CD64-Lin- cells (Live+Singlets+CD19-CD3-B220-
NK1.1-CD64-) in the PECs of T. gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- 
mice 5 days post infection. 
(B) Representative flow contour plots of the gating strategy for CD11c+MHCII+ DCs 
(orange) and MHCII+LY6Chi inflammatory monocytes (green) in the PECs of a T.gondii-
infected B6 mouse 5 days post infection.  
(C) Representative flow contour plots of CD11c+MHCII+IL-12p40+ cells from the PECs 
of T.gondii-infected B6, Il12b-/-,  Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post infection. 
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Fig 5.2 Continued: For all infections 10,000 Pru T. gondii parasites were injected i.p. 
Student’s two-tailed unpaired t-test (* p<0.05, *** p<0.001).  Error bars indicate ± SEM. 
Panel (A) is composed to pooled data from three independent experiments. 
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Fig 5.3. Exogenous IL-12 rescues caspase-8-deficient animals during acute T. gondii 
infection.  
(A) Survival of mice infected with T. gondii and injected i.p. with PBS or rmIL-12p70 
(200ng/mouse) for 7 days post infection (n=3-6).   
(B) Representative cytospins from PECs isolated 5 days post infection from T. gondii-
infected B6,  Il12b-/-,  Ripk3-/-, and Ripk3-/-Casp8-/- mice injected i.p. with PBS or rmIL-
12p70 for 5 days post infection.  
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Fig 5.3 Continued: (C) Quantification of the frequency of infected cells in the PECs of 
PBS or rmIL-12p70-injected T.gondii-infected B6,  Il12b-/-,  Ripk3-/-, and Ripk3-/-Casp8-/- 
mice 5 days post infection, each data point represents a mouse.  
(D) Number and (E) frequency of inflammatory monocytes (Live+Singlets+CD19-CD3-
B220-NK1.1- CD64+MHCII+LY6Chi cells) in the PECs of PBS or rmIL-12p70-injected T. 
gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post infection. 
Each data point represents one mouse.  
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test 
(* p<0.05). (B), (D), and (E) Student’s two-tailed unpaired t-test (n.s. not significant, 
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001).  Error bars indicate ± SEM. Panels 
representative of two independent experiments. 
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Fig 5.4. Exogenous IL-12 rescues c-Rel-deficient animals during acute T. gondii infection.  
Survival of Ripk3-/-Casp8-/-  and Rel-/- mice following T. gondii infection and injected i.p. 
with PBS or rmIL-12p70 (200ng/mouse) for 7 days post infection (n=7 per group).  
Mantel-cox test (** p<0.01). For all infections 10,000 Pru T. gondii parasites were injected 
i.p. Representative of two independent experiments.  
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Fig 5.5. Non-cleavable caspase-8 promotes host survival during acute T. gondii infection.  
(A) Survival of Ripk3-/- , Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA mice  infected with 
T. gondii (n=7-18). 
(B) Frequency of infected cells in the PECs of T.gondii-infected Ripk3-/- , Ripk3-/-Casp8-/- , 
and Ripk3-/-Casp8DA/DA mice  5 days post infection, each data point represents a mouse.  
(C) Frequency of infected cells in the PECs of T.gondii-infected B6, Casp8DA/DA mice, and 
Il12b-/- mice 5 days post infection, each data point represents a mouse. 
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test 
(** p<0.01, *** p<0.001). (B) and (C) Student’s two-tailed unpaired t-test (n.s. not 
significant, * p<0.05).  Error bars indicate ± SEM. Panel (A) represents 3 pooled 
independent experiments. Panels (B) and (C) were performed once.   
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Fig 5.6. Caspase-8 deficiency in hematopoietic cells leads to increased parasite burdens 
and impaired monocyte infiltration during T. gondii infection. 
(A) Frequency of infected cells in the PECs of T. gondii-infected B6.SJL mice irradiated 
and reconstituted with B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- bone marrow 5 days post 
infection, each data point represents an individual mouse.  
(B) Frequency of inflammatory monocytes (Live+Singlets+CD19-CD3-B220-NK1.1-
CD64+MHCII+LY6Chi cells) in the PECs of B6.SJL mice reconstituted with B6, Il12b-/-, 
Ripk3-/-, and Ripk3-/-Casp8-/- bone marrow and infected with T. gondii 5 days post infection. 
Each data point represents a mouse. 
For all infections 10,000 Pru T. gondii parasites were injected i.p. Student’s two-tailed 
unpaired t-test (n.s. not significant, ** p<0.01, *** p<0.001).  Error bars indicate ± SEM. 
Panels show two pooled experiments from a total of three independent experiments.  
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Fig 5.7. Graphical abstract: Caspase-8 promotes secretion of IL-12 in response to T. gondii 
infection.  
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Fig 5.8. Future directions: Potential in vitro mechanism of caspase-8-dependent Il12b 
expression in DCs during T. gondii infection.  
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CHAPTER 6: Non-cleavable caspase-8 mediates host survival during 
infection with the gram-negative bacterial pathogen Yersinia 
pseudotuberculosis. 
6.1 Abstract 
Caspase-8 positively regulates cell-extrinsic apoptosis and constitutively represses 
RIPK3-mediated programmed necrosis, functions critical to immune homeostasis and host 
defense. In addition to its well-characterized role in cell death, caspase-8 regulates 
inflammatory cytokine secretion in vitro and in vivo. Data from our lab as well as others 
have implicated caspase-8 in the immune response during infection with the gram-negative 
enteric pathogens Citrobacter rodentium and Yersinia pseudotuberculosis (Yp).  During 
oral infection Yp mice deficient in caspase-8 in hematopoietic cells have an acute survival 
defect and a cell-intrinsic defect in cytokine production. However, the relative contribution 
of caspase-8-mediated cell death and inflammatory gene expression during Yp infection 
has yet to be elucidated. To begin to resolve this question we generated mice in which 
caspase-8 apoptotic activity was ablated while preserving its cytokine regulatory function. 
We further crossed these mice onto a RIPK3-deficient background to directly compare 
mice without caspase-8 expression to those expressing non-cleavable caspase-8 (non-
apoptotic caspase-8). Mice lacking caspase-8 in both their hematopoietic and 
nonhematopoietic cell populations were acutely susceptible to oral infection with Yp. 
Moreover, expression of non-cleavable  caspase-8 was sufficient to rescue mice during 
infection, and these mice had reduced bacterial burdens. However, we were surprised to 
find that, contrary to what has been observed in mice specifically lacking caspase-8 in their 
hematopoietic cells, mice lacking caspase-8 in all cell populations had no defect in cytokine 
production. These data suggest that the mortality observed in caspase-8-deficient mice was 
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not due to the inability to mount an inflammatory cytokine response or apoptotic response, 
but an alternative function of caspase-8 that is mediated by its non-cleavable conformation.  
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6.2 Introduction 
Caspase-8 is a cysteine protease that mediates cell-extrinsic apoptosis in response 
to activation of death receptors such as Fas and TNFR [102], a function that is critical for 
clearance of autoreactive cell populations [181, 199], tumorigenic cells [182], and virally 
infected cells [128, 183]. Caspase-8 also negatively regulates another form of cell death 
known as programmed necrosis [104, 105] through the cleavage of the K63 deubiquitinase 
CYLD to prevent the activation of RIPK1/RIPK3-dependent necrosis [133]. In addition to 
its role in cell death, caspase-8 has a recently described function in inflammatory cytokine 
expression [75, 100, 110]. Caspase-8 is required for the expression of inflammatory 
mediators in response to fungal [147] and bacterial [77] pathogens in vitro as well as to 
bacterial pathogens in vivo [75, 110]. We have also identified a role for caspase-8-mediated 
cytokine expression in host defense against the eukaryotic, obligate, intracellular pathogen 
Toxoplasma gondii (Chapter 5). However, the relative contributions of caspase-8-
mediated cell death and caspase-8-mediated cytokine secretion to survival during bacterial 
infection has yet to be defined. In this chapter we address the contributions of both of these 
pathways to survival during infection with the gram-negative bacterial pathogen Yersinia 
pseudotuberculosis. 
 Yersinia pseudotuberculosis is closely related to two other pathogenic Yersinia 
spp.: Yersinia enterocolitica and Yersinia pestis. Yersinia enterocolitica and Yersinia 
pseudotuberculosis cause self-limiting gastroenteritis in humans [148, 149], whereas 
Yersinia pestis, the causative agent of plague, has a case-fatality rate of 30-90% when left 
untreated, and is still endemic to the United States [153]. In rodents Y. pseudotuberculosis 
mimics the systemic bacterial dissemination and disease symptomology observed in 
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humans infected with Yersinia pestis [152, 200]. Yersinia spp. are potent activators of 
apoptosis in immune cells via the effector protein YopJ (Yersinia outer protein J) which 
antagonizes gene transcription [154, 155, 178]. We have previously shown that strains of 
Yersinia spp. with reduced YopJ injection are more virulent [174], and apoptosis limits Y. 
pseudotuberculosis virulence in vivo [132]. There is also evidence that in vivo cytokine 
production, particularly IL-12 and TNF, promote host survival to Yersinia infection [98, 
201]. Therefore, it is possible that there are distinct contributions of caspase-8-mediated 
cell death and caspase-8-mediated cytokine secretion to host survival during infection with 
Y. pseudotuberculosis.  
We have previously shown that mice lacking caspase-8 in hematopoietic cells are 
acutely susceptible to oral infection with Y. pseudotuberculosis [114]. Moreover, these 
mice have increased bacterial burdens, and a defect in cytokine production in caspase-8-
deficient monocytes and neutrophils [114]. To test the specific contribution of caspase-8-
mediated cytokine production to host survival during Y. pseudotuberculosis we generated 
a mouse in which the linker sequence between the p10 and p20 subunit of caspase-8 is 
mutated to prevent auto-processing and stabilization of the apoptotic conformation of the 
protein [79, 80]. We have previously shown that macrophages generated from these mice 
are resistant to Yersinia-induced apoptosis, but are able to produce cytokines in response 
to TLR stimuli [75]. These mice were also crossed onto RIPK3-null mice to generate a 
mouse in which both apoptosis and programed necrosis are ablated while preserving the 
cytokine regulatory function of caspase-8. This approach allowed us to specifically 
interrogate the role of caspase-8-mediated cytokine secretion to host defense during oral 
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infection with Yersinia pseudotuberculosis. In this studies we describe an in vivo role for 
caspase-8 that is independent of both its cell death and cytokine regulatory functions.  
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6.3 Results 
6.3.1. Non-cleavable caspase-8 promotes host survival during oral infection with Yersinia 
pseudotuberculosis. 
We have previously shown that mice lacking caspase-8 in their hematopoietic cells 
succumb to oral infection with Yersinia pseudotuberculosis (Yp) within 6 days of infection 
[114]. Surprisingly, mice in which caspase-8 was ablated in all cell populations were even 
more susceptible to Yp infection. Mice began to die 3 days post infection, and all mice 
succumbed within 4 days (Fig 6.1A). We observed a role for RIPK3 in survival beginning 
9 days post infection, which had not previously been observed in mice with hematopoietic-
specific ablation of RIPK3 (Fig 6.1A) [114]. These data potentially implicate RIPK3 in the 
adaptive response to Yp infection which has not been previously reported. One of the seven 
effector proteins expressed by Yp is YopJ, which is known to promote systemic 
dissemination of Yersinia [200];  however, YopJ-mediated apoptosis is also important for 
host survival during Yersinia infection in some contexts [202]. To address the contribution 
of caspase-8-dependent apoptosis in vivo in mice lacking caspase-8 in both their 
hematopoietic and non-hematopoietic cell populations we orally infected Ripk3-/-Casp8-/- 
mice with ΔYopJ. We hypothesized that if caspase-8-dependent apoptosis played a role in 
host survival, mice deficient in caspase-8 would have increased survival during ΔYopJ 
infection, which has been observed in mice with hematopoietic-specific caspase-8 ablation 
[114]. However, Ripk3-/-Casp8-/- mice infected with ΔYopJ succumbed with kinetics 
indistinguishable from mice infected with the parental strain of Yp (Fig 6.1A). These data 
suggested that caspase-8-dependent apoptosis does not mediate host survival during 
infection with Yersinia.  
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We then utilized mice expressing a non-cleavable form of caspase-8 that prevents 
caspase-8-mediated apoptosis while preserving caspase-8-mediated cytokine secretion. We 
found that the apoptotic conformation of caspase-8 was dispensable for survival as the 
kinetics of mortality in Casp8DA/DA and Ripk3-/-Casp8DA/DA mice were indistinguishable 
from B6 and Ripk3-/- mice respectively (Fig 6.1B). From these data we concluded that 
expression of non-cleavable caspase-8 was sufficient to rescue mice from mortality during 
oral Yp infection, implicating caspase-8-mediated cytokine production in host defense 
independently of the role of caspase-8 in apoptosis.  
 
6.3.2. Non-cleavable caspase-8 expression correlates with reduced bacterial burdens during 
oral infection with Yersinia pseudotuberculosis. 
 Mice expressing non-cleavable caspase-8 had reduced bacterial burdens in their 
Peyer’s Patches, spleens, and livers 2 days post infection (Fig 6.2A, Fig 6.2C and 
Fig 6.2D). However, we could observe no difference in mLN bacterial burdens between 
any groups of infected mice (Fig 6.2B). Previous work has shown that there are distinct 
replicating pools of Yp in the oral model of infection [152]. The spread of bacteria is not a 
linear route through Peyer’s Patches to the draining lymph node (mLN), but rather 
replication in the Peyer’s patches occurs in parallel to replication in the small intestine. 
Bacteria originating from the small intestine disseminate to the spleen and liver directly to 
mediate colonization and replication. Therefore, the observed differences in the Peyer’s 
Patches are likely due to differences in the first wave of colonization, and the observed 
differences in the spleen and liver likely reflect dissemination from the small intestine 
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directly. Interestingly, expression of non-cleavable caspase-8 is sufficient to reduce 
bacterial burdens during both forms of colonization.  
 
6.3.3. Systemic IL-12p40 is produced independently of caspase-8 expression.  
 We previously reported that mice with caspase-8 deficiency in their hematopoietic 
cells had reduced levels of inflammatory cytokines in their serum 6 days post infection 
[114]. Therefore, we were surprised to find that mice, in which caspase-8 is ablated in all 
cell populations have wild-type levels of serum IL-12p40 2 days post infection (Fig 6.3). 
We interpret these data to mean that caspase-8 expression is not required to mediate 
cytokine production in this context Furthermore, we observed no additive effect of the 
expression of non-cleavable caspase-8 on a wild-type or RIPK3-null background (Fig 6.3). 
We then tested the inflammatory response on a per-cell basis to determine if immune-cell 
specific cytokine production was impaired in this context.  
 
6.3.4 Cell-intrinsic IL-12p40 expression occurs independently of caspase-8 expression.  
 Two innate cell populations that mount the early inflammatory response to Yp are 
monocytes and neutrophils [75, 98, 114, 132]. In an effort to measure immune-cell specific 
intracellular cytokine responses we selected the mLN, an organ in which bacterial burdens 
were statistically indistinguishable amongst the mice used in these studies. We used this 
approach to control for differences in immune cell recruitment that can be mediated by 
bacterial replication rather than the specific immune state of the host. Using this approach 
we found that mLNs isolated from Ripk3-/-Casp8-/-  mice had a higher frequency of 
IL-12p40 positive monocytes and equivalent cell numbers of IL-12p40 positive monocytes 
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when compared to Ripk3-/- controls (Fig 6.4, Fig 6.5A and Fig 6.5B). We also observed a 
similar trend in IL-12p40 positive neutrophils (Fig 6.4, Fig 6.6A and Fig 6.6B). These data 
were surprising given our findings that caspase-8-deficient hematopoietic cells have a cell-
intrinsic defect in cytokine production [75]. We interpret these data to mean that caspase-
8 is not required for IL-12 production in this context.  
We also observed greater overall numbers of IL-12p40 positive monocytes in 
Ripk3-/-Casp8DA/DA mice, and a higher frequency of IL-12p40 positive monocytes in 
Casp8DA/DA mice. One possible explanation for these data were differences in overall 
monocyte numbers. Therefore, we measured total inflammatory monocytes in naïve and 
infected mice, and found that similar to the phenotype we described in Chapter 4, 
Ripk3-/-Casp8DA/DA mice had higher overall numbers of inflammatory monocytes during 
infection (Fig 6.7A and Fig 6.7B). These results may provide an explanation for the higher 
overall numbers of IL-12p40 positive cells observed in Ripk3-/-Casp8DA/DA mice. We did 
not observe a difference in total numbers of monocytes in naïve or infected Casp8DA/DA 
mice when compared to B6 controls, suggesting that the higher frequency of IL-12p40 
positive cells reflects an increased inflammatory response in these mice (Fig 6.7C and 
Fig 6.7D).  
There was no additive effect of  non-cleavable caspase-8 expression for on a 
RIPK3-null background for cytokine production as measured by neutrophil-derived 
IL-12p40 production (Fig 6.6). This was surprising given the higher overall neutrophil 
numbers we observed at baseline in Ripk3-/-Casp8DA/DA mice (Fig 6.8A). We did observe 
an increase in total neutrophil numbers in infected Ripk3-/-Casp8DA/DA mice when compared 
to Ripk3-/- controls, but this did not correspond to an increase in total IL-12p40 positive 
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neutrophils in these mice (Fig 6.6 and Fig 6.8B). Interestingly, opposite of our observation 
in monocytes, non-cleavable caspase-8 on a wild-type background mediated an increase in 
overall numbers of IL-12 positive neutrophils, but did not impact frequency (Fig 6.6 C and 
Fig 6.6D). We observed a trend toward increased neutrophil infiltrate in the mLNs of 
Casp8DA/DA mice at steady-state and during infection, but this was not statistically 
significant when compared to B6 controls (Fig 6.8C and Fig 6.8D). Collectively, these 
data demonstrate that monocytes and neutrophils produce IL-12p40 independently of 
caspase-8 expression; however, in some cases non-cleavable caspase-8 expression can 
enhance intracellular cytokine production. In all assays that we used we did not observe 
lower levels of global or intracellular cytokine production from Ripk3-/-Casp8-/- mice when 
compared to Ripk3-/- controls, indicating that mice lacking global caspase-8 expression 
have a distinct phenotype from those lacking caspase-8 expression in just the hematopoietic 
compartment.  
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6.4 Discussion  
We have previously shown that caspase-8 deficiency in hematopoietic cells leads 
to acute mortality in response to oral infection with the gram-negative bacterial pathogen 
Yersinia pseudotuberculosis (Yp) [114]. Here we demonstrate that complete ablation of 
caspase-8 in both hematopoietic and non-hematopoietic cells leads to an even more acute 
survival defect in which mice succumb within 4 days of infection. We also observed no 
role for caspase-8-dependent apoptosis in this context as these mice were equally 
susceptible to an isogenic strain of Yp lacking the effector YopJ (ΔYopJ). Mice with 
hematopoietic-specific ablation of caspase-8 largely survive infection with ΔYopJ, but 
mice with global ablation of caspase-8 succumb with kinetics indistinguishable from those 
infected with Yp expressing YopJ. These data led us to conclude that caspase-8-dependent 
apoptosis was dispensable for survival during infection, implicating the cytokine 
regulatory function of caspase-8.  
Two inflammatory cytokine that are critical for host defense during Yp infection 
are TNF and IL-12 [98, 201]. We have previously shown that macrophages derived from 
mice expressing a non-cleavable form of caspase-8 produce endogenous levels of 
cytokines, but to not undergo YopJ-mediated apoptosis during in vitro Yp infection [75]. 
We used these mice as a model to test the contribution of caspase-8-mediated cytokine 
production specifically, and found that these animals survived oral infection with Yp, and 
had reduced bacterial burdens when compared to caspase-8-deficient mice. These data 
were consistent with a model in which caspase-8-dependent cytokine production was 
required for control of Yp infection in vivo. 
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We originally hypothesized that global caspase-8-deficiency would largely 
recapitulate our observations with hematopoietic-specific ablation of caspase-8. However, 
we were surprised to find that mice lacking caspase-8 had no defect in serum cytokines or 
intracellular cytokine production in innate immune cells. Expression of non-cleavable 
caspase-8 was sufficient to reduce bacterial burdens and mediate survival; however, this 
effect appears to be independent of caspase-8-mediated cytokine secretion. Caspase-8-
deficient mice, and mice expressing non-cleavable caspase-8, largely had no detectible 
differences in serum cytokines or intracellular cytokine production by monocytes or 
neutrophils. We interpret these data to mean that caspase-8 expression is not required for 
the early cytokine response to Yp. Intriguingly, these data suggested that there is an 
alternative role for caspase-8 in regulating bacterial dissemination or replication 
independently of cell death or cytokine secretion.  
One possible explanation for the discrepancy between mice with total caspase-8 
ablation and mice with hematopoietic-specific ablation is developmental differences 
between these mice. There are no reported developmental defects in the intestines of Ripk3-
/-Casp8-/- mice. However, this may be due to the focus on the immune compartment of 
these mice as they display acute lymphoproliferative disease [104, 105]. We have 
previously implicated caspase-8 in pro-inflammatory gene expression in macrophages 
downstream of TLR signaling, but it is possible that it interacts with some of these 
signaling intermediates in other cell types such as intestinal epithelial cells. Homeostatic 
turnover of intestinal epithelial cells is primarily mediated by TNF signaling, which is 
upstream of caspase-8 activation [203]. Additionally, mice deficient in TAK1 or the 
transcription factor p65 in their intestinal epithelium have increased ROS production and 
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intestinal apoptosis respectively [203, 204]. c-Rel has also been implicated in epidermal 
homeostasis through the regulation of cell cycle genes [205], but it is also possible that this 
regulation also occurs in intestinal epithelial cells. In Chapter 2 we note that caspase-8 
deficiency leads to impaired expression of cell cycle genes in macrophages in response to 
TLR stimulation. Therefore, it would be interesting to see if caspase-8 and c-Rel also play 
a role in intestinal epithelial cell homeostasis. If caspase-8 mediates development of the 
small intestine or barrier integrity during steady-state then the survival defect we observed 
in mice globally deficient in caspase-8 may be due to failure to control bacterial 
dissemination from the small intestine. Expression of non-cleavable caspase-8 may be 
sufficient to maintain barrier integrity, in turn promoting survival of the host. Future studies 
that interrogate the role of caspase-8 in intestinal epithelial cell homeostasis and barrier 
integrity may help elucidate the mechanism of caspase-8-dependent protection during oral 
infection with Yp. Collectively, these studies show, for the first time, that caspase-8 non-
apoptotic activity is sufficient to mediate survival during Yp infection, and that this 
protection occurs independently of the cytokine regulatory function of caspase-8 (Fig 6.9).  
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6.5 Figures 
 
Fig 6.1. Non-cleavable caspase-8 promotes host survival during oral infection with 
Yersinia pseudotuberculosis. 
(A) Survival of B6, Ripk3-/-, and Ripk3-/-Casp8-/- mice (n=10-11) infected o.g. (3-4x10^8 
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) and ΔYopJ Yersinia 
pseudotuberculosis (IP2777).  
(B) Survival of B6, Ripk3-/- , Ripk3-/-Casp8-/-, Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice 
(n=10) infected o.g. (4x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 
Mantel-cox test ( n.s. not significant , **** p<0.0001). Panel (A) and (B) performed once.  
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Fig 6.2. Non-cleavable caspase-8 expression correlates with reduced bacterial burdens 
during oral infection with Yersinia pseudotuberculosis. 
Bacterial burdens in the Peyer’s Patches (A), mLNs (B), spleens (C) and livers (D) of B6, 
Ripk3-/-, Ripk3-/-Casp8-/-, Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice infected o.g. (2-3x10^8 
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle 
represents a mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant, *p<0.05, **p<0.01, 
*** p<0.001).  Error bars indicate ± SEM. Data pooled from two independent experiments.  
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Fig 6.3. Systemic IL-12p40 is produced independently of caspase-8 expression. 
ELISA measurement of serum IL-12p40 from B6, Ripk3-/-, Ripk3-/-Casp8-/-, 
Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice infected o.g. (2-3x10^8 CFU/mouse) with 
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a 
mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant). Error bars indicate ± SEM. Data 
pooled from two independent experiments. 
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Fig 6.4. Flow-cytometry gating strategy for innate immune populations during oral 
infection with Yersinia pseudotuberculosis.  
Representative flow contour plots of the gating strategy for neutrophils 
(CD45+Lin-CD11b+Ly6G+) and inflammatory monocytes (CD45+Lin-CD11c-
Ly6ChiMHCII+) in the mLN of a B6 mouse infected o.g. (3x10^8 CFU/mouse) with 
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. All samples pre-gated on live 
single cells. Lin markers (CD3, B220).  
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Fig 6.5 Monocyte IL-12p40 expression is independent of caspase-8. 
(A) Frequency and (B) total numbers of IL-12p40+ inflammatory monocytes in the mLNs 
of Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice infected o.g. (3x10^8 
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle 
represents a mouse.  
(C) Frequency and (D) total numbers of IL-12p40+ inflammatory monocytes in the mLNs 
of B6 and Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia 
pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01, 
*** p<0.001).  Error bars indicate ± SEM. Data representative of two independent 
experiments. 
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Fig 6.6. Neutrophil IL-12p40 expression is independent of caspase-8. 
(A) Frequency and (B) total numbers of IL-12p40+ neutrophils in the mLNs of Ripk3-/-, 
Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with 
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a 
mouse.  
(C) Frequency and (D) total numbers of IL-12p40+ neutrophils in the mLNs of B6 and 
Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis 
(IP2777) 2 days post-infection. Each circle represents a mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01, 
*** p<0.001).  Error bars indicate ± SEM. Data representative of two independent 
experiments. 
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Fig 6.7 RIPK3-null mice expressing non-cleavable caspase-8 have higher levels of 
monocyte infiltration during Yersinia pseudotuberculosis infection.  
(A) Total numbers of monocytes in the mLNs of naïve Ripk3-/-, Ripk3-/-Casp8-/-, and 
Ripk3-/-Casp8DA/DA mice. Each circle represents a mouse.  
(B) Total numbers of monocytes in the mLNs of Ripk3-/-, Ripk3-/-Casp8-/-, and 
Ripk3-/-Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia 
pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a mouse.  
(C) Total numbers of monocytes in the mLNs of naïve B6 and Casp8DA/DA mice. Each 
circle represents a mouse. 
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Fig 6.7 Continued: (D) Total numbers of monocytes in the mLNs of B6 and Casp8DA/DA 
mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days 
post-infection. Each circle represents a mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01).  Error bars 
indicate ± SEM. Panels (A) and (C) are each pooled from two independent experiments. 
Panels (B) and (D) are each representative of two independent experiments. 
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Fig 6.8  RIPK3-null mice expressing non-cleavable caspase-8 have higher neutrophil 
numbers at steady-state.  
(A) Total numbers of neutrophils in the mLNs of naïve Ripk3-/-, Ripk3-/-Casp8-/-, and 
Ripk3-/-Casp8DA/DA mice. Each circle represents a mouse.  
(B) Total numbers of neutrophils in the mLNs of Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/-
Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis 
(IP2777) 2 days post-infection. Each circle represents a mouse.  
(C) Total numbers of neutrophils in the mLNs of naïve B6 and Casp8DA/DA mice. Each 
circle represents a mouse. 
 144 
Fig 6.8 Continued: (D) Total numbers of neutrophils in the mLNs of B6 and Casp8DA/DA 
mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days 
post-infection. Each circle represents a mouse.  
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05).  Error bars indicate ± 
SEM. Panels (A) and (C) are each pooled from two independent experiments. Panels (B) 
and (D) are each representative of two independent experiments. 
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Fig 6.9. Graphical abstract and future directions: Caspase-8 promotes host survival during 
oral infection with Yersinia pseudotuberculosis independently if its cytokine regulatory or 
apoptotic functions. 
  
 146 
CHAPTER 7: Discussion and future directions. 
7.1 Summary of findings  
In this study we hypothesized that caspase-8 enzymatic activity would play a role 
in inflammatory gene expression independently of its apoptotic function, and that 
caspase-8-mediated inflammatory gene regulation would be required for host defense 
against a variety of pathogens in vivo. In Chapter 2 we identified the mechanism by which 
caspase-8 regulates the inflammatory cytokines IL-12 and IL-1β through the NF-κB family 
member c-Rel. We also showed that expression of c-Rel in caspase-8-deficient 
macrophages is sufficient to restore production of both IL-12 and IL-1β.  In Chapter 3 we 
tested the role for caspase-8 enzymatic activity in c-Rel translocation and inflammatory 
gene expression. We found that both the enzymatic and non-enzymatic functions of 
caspase-8 mediate c-Rel translocation and expression of caspase-8-dependent 
inflammatory genes. These results help address a long-standing conflict in the field 
regarding the relative contributions of caspase-8 enzymatic and non-enzymatic activity to 
gene expression.  
In Chapter 4 we defined a role for caspase-8 apoptotic activity and RIPK3-
mediated programed necrosis in steady-state levels of myeloid cell populations in 
secondary lymphoid organs. These data implicate caspase-8 in innate immune cell turnover 
for the first time. In Chapter 5 we identified a role for caspase-8-mediated cytokine 
secretion in host defense during acute infection with the eukaryotic pathogen Toxoplasma 
gondii. To our knowledge this is the first report of caspase-8 mediating host survival 
against a eukaryotic pathogen in vivo. In Chapter 6 we identified a role for caspase-8 in 
host survival during infection with the gram-negative enteric pathogen Yersinia 
pseudotuberculosis. We found that survival during Yersinia infection was mediated 
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independently of caspase-8-dependent apoptosis and caspase-8-dependent pro-
inflammatory cytokine production. These data potentially implicate caspase-8 in 
maintenance of intestinal barrier integrity for the first time. Collectively, these studies 
highlight the broad role for caspase-8 in immune homeostasis as well as host defense. 
Moreover, they suggest that many functions of caspase-8 are independent of caspase-8-
mediated apoptosis.  
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7.2 Key findings of this work 
7.2.1 Distinct regulation of the NF-κB family members p65 and c-Rel is mediated, in part, 
through caspase-8. 
Our data implicate caspase-8 in the distinct regulation of c-Rel and p65 in response 
to TLR stimulation. Early work described a restricted role for c-Rel in Il12b expression in 
macrophages [71]. However, our data identified many caspase-8-dependent genes that 
were also dependent on the expression of c-Rel, potentially implicating c-Rel in the 
regulation of other genes in response to TLR activation. The mechanisms by which c-Rel 
and p65 are distinctly regulated in macrophages has yet to be elucidated; however, it is 
possible that caspase-8 represents one mechanism to orchestrate their distinct activation. 
NF-κB family-member regulation can be categorized as either  canonical and non-
canonical NF-κB signaling pathways that mediate differential regulation of p65 and RelB 
respectively [206-209]. The classification of canonical and non-canonical NF-κB signaling 
is largely based on the differential utilization of NEMO and IKKα respectively [210, 211]. 
While entirely speculative, it is possible that in macrophages differential activation of c-
Rel and p65 can be characterized based on the utilization of caspase-8.  
We also observed a selective effect of caspase-8-dependent IKKα/β 
phosphorylation on the degradation of IκBε. IκBε is thought to preferentially associate with 
both p65 and c-Rel, and recent evidence describes a role for IκBε/c-Rel specific 
interactions in certain cell-types [176, 212]. Like other IκB proteins, IκBε is degraded by 
the ubiquitin-26S proteasome pathway [57, 58]. However, IκBε can also be degraded by 
the REGγ proteasome in non-hematopoietic cells in vivo [213]. These data suggest there 
may be other mechanisms of IκBε regulation that are independent of IKK-mediated 
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degradation. Previously uncharacterized mechanisms of proteasomal degradation may 
provide an explanation for the distinct regulation of IκBε and IκBα in a caspase-8-deficient 
setting. Further experiments to test the hypothesis that there is preferential association 
between c-Rel and IκBε in macrophages will help elucidate how p65 and c-Rel are 
distinctly regulated in this context. Testing the biochemical sensitivities of the IκB proteins 
to differing levels of IKK phosphorylation may also provide insight into the seemingly 
increased sensitivity of IκBε to perturbations in IKKα/β phosphorylation. Other studies 
have primarily focused on the temporal regulation of IκB protein expression [59], but these 
do not address the threshold of IKKα/β activation required to mediate the degradation of 
IκB proteins.  
One looming question from these studies is how exactly caspase-8 regulates IKK 
activation. We could find no role for caspase-8 in the activation of the upstream kinases 
TAK1 or TBK1 that are classically thought to promote IKK activation [211, 214, 215]. 
One possible explanation may be the specific requirement for NIK (Mitogen-activated 
protein kinase kinase kinase kinase 4) in this signaling pathway. NIK is activated in 
response to both CD40 and TNF to promote IKK phosphorylation [207, 209]. One caveat 
to this hypothesis is that NIK is constitutively degraded by TRAF3 at steady state, and the 
kinetics of TRAF3 degradation and NIK activation may not be concordant with the role of 
caspase-8 in the rapid response to TLR stimulation. However, it is still possible that NIK 
plays a role in our system; therefore, we will test the impact of caspase-8 on NIK activation 
specifically, which may help elucidate the mechanism by which caspase-8 mediates IKK 
activation.   
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7.2.2 Caspase-8 regulates inflammatory gene expression through both its enzymatic and 
non-enzymatic activity.  
In Chapter 3 we demonstrated a role for caspase-8 enzymatic activity in the 
expression of pro-inflammatory cytokines in response to both TLR4 and TLR9 activation. 
These data provoke the hypothesis that caspase-8 regulates inflammatory gene expression 
through its cleavage activity. A candidate substrate for caspase-8 would need to meet two 
key requirements: (1) the substrate would need to be cytoplasmic, as caspase-8 has no NLS 
and is not known to localize to the nucleus; additionally, (2) the caspase-8 substrate is likely 
a negative regulator of IKK activation based on the finding that inhibition of caspase-8 
enzymatic activity reduced IKK phosphorylation to the same magnitude observed in 
caspase-8-deficient cells. Earlier in this project we tested several potential caspase-8 
targets, including HDAC7 and EHMT1, which have both cytoplasmic and nuclear 
localization as well as putative caspase-8-cleavage sites. However, these proteins are much 
more distal to TLR stimulation than IKK phosphorylation [216-218], and—perhaps not 
surprisingly—inhibition of HDAC7 or EHMT1 was not sufficient to restore inflammatory 
cytokine transcription in caspase-8-deficient cells (data not shown). Another logical 
candidate for caspase-8 cleavage is the linear deubiquitinase CYLD which cleaves K63 
ubiquitin on RIPK1 [133]. Ubiquitination of RIPK1 is known to mediate expression of pro-
survival genes during TNFR activation through the recruitment of NEMO, IKKα, and 
IKKβ [106, 107]. However, siRNA knock down of CYLD was not sufficient to restore 
cytokine secretion in caspase-8-deficient cells (data not shown).  
Although these data are not conclusive, they suggest there is a cytoplasmic target 
of caspase-8 that has yet to be identified. Recently caspase-8 has been implicated in 
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maintenance of chromosome stability through the cleavage of Polo-like kinase 1 (PLK1) a 
mediator of centrosome assembly and spindle maturation during the M-phase of cell 
division [219]. Given our findings regarding the role of caspase-8 in cell cycle gene 
regulation (Chapter 2), it is tempting to speculate that PLK1 may play a previously 
uncharacterized role in TLR-induced inflammation in macrophages. We are interested in 
testing the impact of PLK1 inhibition during TLR stimulation in caspase-8-deficient 
macrophages. We hypothesize that if PLK1 is a target of caspase-8 in response to TLR 
stimulation then inhibition of PLK1 should be sufficient to restore inflammatory cytokine 
transcription in caspase-8-deficient cells. It is also possible that caspase-8 cleaves PLK1 in 
macrophages, but this cleavage does not mediate inflammatory gene expression. However, 
PLK1 cleavage may be the primary mechanism of caspase-8-mediated cell cycle gene 
regulation during TLR stimulation. Regardless of the outcome of these experiments we 
will gain further insight into the diverse array of caspase-8 cleavage targets during TLR 
stimulation.   
Another set of experiments we are interested in performing are unbiased proteomics 
to identify novel caspase-8 cleavage targets. This approach would utilize a method known 
as TAILS (Terminal amine isotopic labeling of substrates) which identifies novel N-termini 
through TMT labeling [220]. We hypothesize that caspase-8-sufficent macrophages will 
have specific N-termini that are absent in caspase-8-deficient cells upon TLR stimulation. 
This approach would allow us to identify a variety of caspase-8 substrates, and combine 
this data with our knowledge regarding caspase-8 and IKK activation to identify potential 
candidates for further analysis.  
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7.2.3 Caspase-8 regulates cell cycle gene expression in response to multiple TLRs. 
The most surprising result to emerge from these studies was the finding that 
caspase-8 deficiency leads to a defect in cell cycle gene expression during TLR stimulation 
(Chapter 2). Expression of cell cycle-related genes was impaired in caspase-8-deficient 
cells during both TLR4 and TLR9 stimulation (Fig 2.2B and Fig 2.2D). These data were 
particularly interesting in light of recent evidence that caspase-8 cleaves PLK1 a mediator 
of centrosome assembly and spindle maturation during the M-phase of cell division [219]. 
The study describing caspase-8-mediate cleavage of PLK1 was conducted in tumor-
derived cell lines as well as mouse embryonic fibroblasts (MEFs); therefore, these data 
may not be generalizable to all cell types. However, there is evidence that c-Rel regulates 
cell cycle progression in B cells [221, 222], potentially implicating c-Rel, PLK1, and 
caspase-8 in cell cycle gene regulation. Collectively, these studies lead us to hypothesize 
that PLK1 may play a role in cell cycle gene expression in macrophages. To test this 
hypothesis we plan to inhibit and transiently ablate PLK1 in caspase-8-deficient 
macrophages. Our expectation is that loss of PLK1 function will be sufficient to restore 
cell cycle gene expression in caspase-8-deficient cells. We will further test the ability of 
caspase-8 to cleave PLK1 directly to determine if PLK1 is a substrate of caspase-8 during 
TLR activation.  
Another potential area of investigation is the impact of caspase-8 on cell cycle 
progression myeloid in cell populations such as monocytes. We hypothesize that caspase-8 
cleavage of PLK1 would promote differentiation of monocytes in response to TLR 
stimulation. TLR activation is known to induce monocyte differentiation into macrophages 
[223], and caspase-8 may be one mechanism that promotes this rapid differentiation. Our 
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future investigations will focus on elucidating the mechanism by which caspase-8 regulates 
cell cycle gene expression in a TLR-dependent manner.  
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7.2.4 Caspase-8-dependent apoptosis, and RIPK3-mediated programmed necrosis may 
regulate steady-state numbers of myeloid cells.  
In an effort to elucidate the contribution of caspase-8-mediated cytokine production 
in vivo, we generated a mouse in which the apoptotic conformation of caspase-8 is rendered 
unstable while preserving its cytokine regulatory function (Casp8DA/DA) [75]. Caspase-8 is 
also known to negatively regulate another cell death pathway known as RIPK3-mediated 
programed necrosis [104, 105]. Mice deficient in caspase-8 do not survive embryonic 
development because of the de-repression of programed necrosis. Dual ablation of 
caspase-8 and RIPK3 rescues mice from embryonic lethality. We further crossed 
Casp8DA/DA mice onto a RIPK3-null background to facilitate direct comparison between 
mice completely lacking caspase-8, and mice lacking caspase-8 apoptotic activity 
specifically. Ripk3-/-Casp8-/- mice display a lymphoproliferative disease that is similar to 
that observed in mice lacking Fas or FasL, and this phenotype is attributed the inability of 
Ripk3-/-Casp8-/- mice to undergo caspase-8-mediated apoptosis [104, 105]. Therefore, we 
hypothesized that mice expressing non-cleavable caspase-8 on a RIPK3-null background 
would also display a similar lymphoproliferative disease.  
 We were surprised to find that Ripk3-/-Casp8DA/DA mice had a distinct phenotype 
from Ripk3-/-Casp8-/- mice. Ripk3-/-Casp8DA/DA mice had morphological defects in splenic 
architecture, and an accumulation of myeloid cells in secondary lymphoid organs (Chapter 
4). At steady-state we could not observe an increase in total myeloid cell numbers in 
Ripk3-/-Casp8-/- mice (Chapter 6), suggesting that the accumulation of myeloid cells is a 
unique feature of mice expressing non-cleavable caspase-8. Furthermore, we did not detect 
a statistical difference in myeloid populations in the mLNs of B6 and Casp8DA/DA mice. 
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(Chapter 6). We interpret these data to mean that the phenotype of Ripk3-/-Casp8DA/DA 
mice is dependent on both the expression of non-cleavable caspase-8 and 
RIPK3-deficiency. These data implicate caspase-8 in another mechanism of immune cell 
homeostasis that is entirely dependent on its apoptotic activity. Further studies that identify 
the time of onset of myeloid accumulation in Ripk3-/-Casp8DA/DA mice, as well as the origin 
of this myeloid cell population, will provide insight into the role caspase-8-mediated 
apoptosis plays in myeloid circulation at steady-state.  
These data provoke the hypothesis that caspase-8-mediated apoptosis plays a 
cell-intrinsic role in turnover of myeloid cell populations in the periphery. An approach 
that utilizes reciprocal bone marrow chimeras in which we transfer Ripk3-/-Casp8DA/DA 
hematopoietic cells into Ripk3-/-Casp8-/- mice will help us determine if cell-intrinsic 
expression of non-cleavable caspase-8 in hematopoietic cells is sufficient to mediate this 
phenotype. Moreover, we should observe no accumulation of these cell populations in 
Ripk3-/-Casp8DA/DA reconstituted with Ripk3-/-Casp8-/- bone marrow as complete caspase-8 
ablation appears sufficient to protect mice from the accumulation of myeloid cells. It is 
also possible the observed phenotype in Ripk3-/-Casp8DA/DA mice is due to non-cleavable 
caspase-8-mediated expression of chemokines that promote myeloid cell egress from the 
bone marrow. We have shown a role for caspase-8 in the expression of Cxcl2 in 
macrophages in response to TLR stimulation (Chapter 2).  The chemokine CXCL2 
mediates myeloid cell egress from the bone marrow via CCR2 [224]. Therefore, it is 
possible that caspase-8-dependent CXCL2 promotes myeloid cell egress, but there is no 
cell turnover in the periphery due to a defect in caspase-8-dependent apoptosis. To test the 
contribution of caspase-8-mediated CXCL2 secretion we would generate mixed bone 
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marrow chimeras in which Ripk3-/-Casp8DA/DA mice are reconstituted with Ccr2-/- bone 
marrow, with the expectation that this will abrogate myeloid accumulation in the periphery. 
These proposed experiments will help to elucidate the mechanism of myeloid cell 
accumulation in Ripk3-/-Casp8DA/DA mice at steady-state. 
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7.2.5. Caspase-8 mediates host survival during infection with Toxoplasma gondii. 
 Others have described a role for caspase-8-mediated cytokine production in 
response to fungal and bacterial pathogens in vitro as well bacterial pathogens in vivo [75, 
77, 100, 110, 147]. To our knowledge, our studies are the first to implicate caspase-8 in 
host defense during infection with Toxoplasma gondii (Chapter 5). The mechanism of 
caspase-8-mediated resistance to T. gondii is likely through its cytokine regulatory 
function. Caspase-8-deficient DCs had impaired intracellular IL-12 production, and 
caspase-8-deficient animals had impaired recruitment of inflammatory monocytes into the 
site of infection. Moreover, caspase-8-deficient mice could be completely rescued through 
endogenous injection of IL-12. These data, while correlative, suggest a cell-intrinsic role 
for caspase-8-mediated cytokine production in vivo in response to T. gondii. To directly 
test the contribution of caspase-8-mediated IL-12 production in DCs we plan to generate 
mixed bone marrow chimeras with congenically labeled bone marrow from Ripk3-/-Casp8-
/- and Zbtb46-cre IRF8-floxed mice—in which conventional type 1 dendritic cells are 
selectively ablated [197]. Transferring this mixed bone barrow into a sublethally irradiated 
Ripk3-/-Casp8-/- host will allow us to determine if intracellular production of IL-12 in Ripk3-
/-Casp8-/- DCs is rescued by caspase-8-sufficient bone marrow via bystander effects, or if 
caspase-8-deficient DCs still have impaired IL-12 production. The later result would 
suggest a cell-intrinsic defect in cytokine production.  
 Another area of investigation is the role of caspase-8 in host defense during 
infection with another Apicomplexan parasite: Cryptosporidium. parvum. Infection with 
Cryptosporidium spp. causes severe developmental delays in infected children with the 
highest prevalence rate in developing countries [225, 226]. It has only recently become 
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possible to passage these parasite in tissue culture to facilitate infection of different strains 
of immunocompromised mice [198]. Little is known about the mechanism of host defense 
against C. parvum or the mechanism of C. parvum antagonism of the immune system. 
Given the role of caspase-8 in protecting mice against the related pathogen T. gondii it is 
plausible that caspase-8 plays a similar role during C. parvum infection. Caspase-8 likely 
plays a much more extensive role in defense against bacterial, fungal, and protozoan 
pathogens through both its apoptotic and cytokine regulatory functions, and we hope the 
studies described in Chapter 5 serve as a basis for further investigation into 
caspase-8-mediated host defense. 
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7.2.6 Caspase-8 may play a role in intestinal epithelial cell homeostasis at steady-state and 
during infection.  
 In Chapter 6 we show that global ablation of caspase-8 and hematopoietic-specific 
ablation of caspase-8 have distinct impacts on the inflammatory response to the 
gram-negative bacterial pathogen Yersinia pseudotuberculosis (Yp). Hematopoietic-
specific ablation of caspase-8 leads to acute host mortality, increased bacterial burdens, 
and impaired inflammatory response during oral infection with Yp. Global ablation of 
caspase-8 results in acute host mortality, and higher systemic bacterial burdens, but no 
impairment in inflammatory cytokine production. Moreover, caspase-8 apoptotic activity 
seems to be dispensable for Yp-protection in this context. Expression of non-cleavable 
caspase-8 was sufficient to reduce bacterial burdens and limit host mortality. These data 
suggest that caspase-8 may play a role in non-hematopoietic cells that is independent of 
both its cytokine regulatory function and apoptotic function. These results led us to 
hypothesize that caspase-8 plays a role in epithelial cell turnover in the small intestine. 
 The systemic dissemination we observed two days post infection in 
caspase-8-deficient animals may be mediated by a disruption in barrier integrity in the 
small intestine. Previous groups have shown that colonization of livers and spleens in 
Yp-infected animals is mediated by bacterial translocation directly from the small intestine. 
It is tempting to speculate that the role of caspase-8 in cell cycle gene expression may be a 
common function of caspase-8 in other cell types, including intestinal epithelial cells. 
Recent data has shown that mouse embryos lacking caspase-8 have defects in mitotic 
alignment in their colons, skin, and livers [219]. Immunohistochemical analysis of the 
small intestine of caspase-8-deficient and caspase-8-sufficient animals at steady-state, and 
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during Yp infection, will help us test the hypothesis that caspase-8 mediates barrier 
integrity. We would also like to perform live imaging of 3D organoid cultures derived from 
Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice to test the hypothesis that caspase-8 
regulates cell division in this context [227]. Caspase-8 expression is dysregulated in 
tumorigenic tissue [182], and previous work has largely focused on the impact that this 
disruption has on apoptosis of tumorigenic cells [228, 229]. However, recent data that 
demonstrate a role for caspase-8 in cell cycle progression [219] suggest that caspase-8 has 
multiple roles in the prevention of tumor development, potentially expanding the viable 
caspase-8 targets during tumor therapy. 
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7.3 Concluding remarks 
 The mechanisms that govern the spectrum of immune activation have far reaching 
implications for human disease. Chronic inflammation leads to diseases that have become 
globally pervasive: inflammatory bowel disease, diabetes, and heart disease among others. 
And prolonged immune suppression leads to the outgrowth of tumorigenic cells and 
chronic infection. In these studies we have implicated caspase-8 as a protein that regulates 
the magnitude of immune activation during infection. We have shown that caspase-8 
enzymatic activity contributes to both cell death and cell-intrinsic cytokine production. 
Moreover, it is likely that in a heterogenous environment in vivo caspase-8 promotes both 
cell death and cytokine secretion in distinct cells to ultimately facilitate pathogen clearance 
while dictating the appropriate level of immune activation. We propose that caspase-8 
serves as a regulatory node to integrate both cell-death-inducing and pro-inflammatory 
stimuli, in turn mediating a rapid intracellular response that is dependent on the 
extracellular environment. In this way, a given cell is rapidly poised to undergo either cell 
death or secrete inflammatory mediators, but ultimately the context of the environment 
dictates the final outcome. It is clear from the studies described here as well as emerging 
literature that cell death and inflammation are intrinsically linked. We hope that the data 
described in this thesis begin the process of supplanting models in which inflammation and 
cell death are easily separable pathways with a new model in which there is an appreciation 
for the integration between these two essential biological processes.  
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CHAPTER 8: Materials and Methods 
8.1 Experimental Model and Subject Details 
8.1.1 Mice  
C57BL/6 mice were obtained from Jackson Laboratories. The Ripk3-/-Casp8-/- mice 
and Mlkl-/-Fadd-/- mice used in these studies have been described previously [105, 127], 
and were provided by Doug Green (St. Jude Children’s Research Hospital). Ripk3-/- mice 
were provided by Vishva Dixit (Genentech). Il12b-/- mice were previously described and 
provided by the Hunter lab [230]. Rel-/- mice were generated and provided by Hsiou-chi 
Liou [231]. Casp8DA/DA mice were previously described [75]. These mice were further 
crossed onto Ripk3-/- mice for 8 generations. For animal experiments, age- and sex-matched 
8-12-week old mice were used. 
All animal studies were performed in compliance with the federal regulations set 
forth in the Animal Welfare Act (AWA), the recommendations in the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of Health, and the guidelines of 
the University of Pennsylvania Institutional Animal Use and Care Committee. All 
protocols used in this study were approved by the Institutional Animal Care and Use 
Committee at the University of Pennsylvania (Multiple Project Assurance # A3709-01, 
Protocol #804523, Protocol #805045).  
8.1.2. Toxoplasma gondii 
Transgenic Pru-tdTomato parasites were generated as previously described [232]. 
Parasites were maintained in vitro in a 37°C 5% CO2 humidified incubator by serial 
passage through human foreskin fibroblasts in DMEM supplemented with 20% M199, 
10% fetal bovine serum, 1% pencillin-streptomycin,  and 25 μg/ml gentamicin. 
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Tachyzoites were prepared for infection by serial needle passage and filtered through a 5-
μm pore-size filter. Mice were infected i.p. with 104 live, invasion-competent parasites.  
 
8.1.3. Yersinia pseudotuberculosis 
Mice were fasted for 12–16 hours and infected orally with 2–4 x 108 Yersinia 
(32777) or  ΔYopJ (32777) as indicated. Mice were monitored for survival or sacrificed 
and tissues were harvested 2 days post-infection, as indicated. Bacterial load was 
determined by plating dilutions of tissue homogenates on LB+irgasan plates, serum 
cytokines were measured using ELISA, and single-cell analysis was performed by flow 
cytometry. 
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8.2 Method Details 
8.2.1 Bone marrow chimeras 
6-week-old female B6.SJL mice were sublethally irradiated with 1100 rads. Mice 
were injected with 2-5x106 cells from bone marrow isolated from B6, Il12b-/-, Ripk3-/-, 
Ripk3-/-Casp8-/- mice 6hrs post irradiation. Mice were given Sulfatrim in their water for 3 
weeks. Infections were performed 10-12 weeks after irradiation and reconstitution.   
 
8.2.2 BMDM electoporation and hc-Rel plasmid 
Bone marrow derived macrophages (BMDMs) were grown as described in section 
8.2.4. Cells were harvested from petri-dishes in 4°C PBS without calcium and magnesium. 
Cells were electroporated using the  Amaxa’s nucleofection procedure using 9 million 
BMDMs and 12ug of plasmid per condition. hc-Rel IRES-GFP containing plasmid and 
empty vector controls were made on a modified pBent2 plasmid. The plasmid cloning 
method has been previously described [50], and plasmids were purified prior to 
electroporation using the Qiagen Plasmid Maxi Kit.  
 
8.2.3 Caspase-8 activity assay  
BMDMs were pre-treated for 1hr with zVAD-fmk (100 μM SM Biochemicals) and 
stimulated with LPS (E.coli O55: B5 LPS Sigma, 100 ng/mL) or 1 μM CpG (IDT) for  
30min or staurosporine (10 μM Sigma) for 3.5hrs. Caspase-8 activity was measured using 
the Caspase-8 fluorometric assay kit (Enzo, #ALX-850-222-K101). Fluorescence was read 
30 minutes after substrate incubation per kit instructions.  
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8.2.4 Cell culture  
BMDMs were grown as previously described [202] in a 37°C 5% CO2 humidified 
incubator in DMEM supplemented with 10% FBS, HEPES, sodium pyruvate (complete-
DMEM) and 30% L929 supernatant for 7–9 days. 16–20 hrs prior to treatment cells were 
re-plated into 96-, 48-, 24-, 12- or 6-well dishes in complete-DMEM containing 10% L929 
supernatant. Cells were incubated at 37°C post-stimulation. zVAD-fmk (100 μM) or IETD-
fmk (500 μM SM Biochemicals) was added 1 hr prior to treatment with LPS (100 ng/mL) 
or CpG (1μM). The generation of immortalized cells and retroviral transduction were 
previously described [114].   
 
8.2.5 ChIP-qPCR 
 BMDMs were stimulated with LPS (100ng/mL) for indicated time points. Cells 
were cross linked with disuccinimidyl glutarate (Thermo Fisher) and formaldehyde 
(Sigma). Nuclear lysis was performed with the truChIP Chromatin Shearing Reagent KIT 
(Covaris) and nuclei were sonicated using the Covaris S220 sonicator. Chromatin was 
immunoprecipitated using anti-p65 antibody (sc-372X Santa Cruz) and anti-c-Rel antibody 
(sc-71X Santa Cruz) and protein G agarose beads (Millipore). All samples were column 
purified with the QIAquick PCR purification Kit (Qiagen). qPCR was performed using 
SYBER Green PCR Master Mix (Thermo Fisher) with 45 cycles of 95˚C(15s), 60˚C(30s) 
and 72˚C(30s). Primer pairs were designed to amplify 80-250 bp fragments of the promoter 
region of each gene and melt curve analysis was used to confirm the amplification of 
unique products. Primer sequences used are listed in the Appendix. 
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8.2.6 Confocal Microscopy 
BMDMs were seeded on round, glass coverslips in 24-well plates and allowed to 
adhere overnight. BMDMs were pre-treated for 1hr zVAD-fmk (100 μM)  where indicated 
and stimulated with LPS (100 ng/mL) or CpG 1 μM CpG for 2hrs. BMDMs were fixed 
with 4% PFA, permeabilized with 0.2% Triton, and blocked in 10% BSA. BMDMs were 
incubated with p65 (CST #8242, 1:200) and c-Rel(Santa Cruz #365720, clone G-7, 1:25) 
primary antibodies for 2 hours at 37°C, 5% CO2 in 4% BSA. BMDMs were washed in PBS 
and incubated with Alexa Fluor rabbit 488 (Thermo Fisher, 1:5000) and Alexa Fluor mouse 
488 (Thermo Fisher, 1:5000) at room temperature for 1 hour in 4% BSA. BMDMs were 
washed in PBS and stained with Hoechst (Fisher Scientific, 1:2500) and Alexa Fluor 647 
Phalloidin (Thermo Fisher, 1:50) for 30 min in PBS at RT. Coverslips were washed, 
mounted on glass slides with Fluoromount-G (Thermo Fisher) and dried overnight at RT. 
Slides were imaged on a Leica SP5-II Confocal/FLIM Microscope at 63x. Three single 
image slices each containing 20-50 cells were taken for each genotype and condition. Cells 
imaged for display were imaged at an additional 2.5x. The brightness and contrast of 
display images were enhanced equally across genotypes using ImageJ, with each channel 
enhanced separately using secondary only, Rel-/- BMDMs, and unstained controls. Images 
used for quantification were not altered. Nuclear and cytoplasmic intensity of c-Rel and 
p65 was analyzed with the Multi Wavelength Cell Scoring application within MetaMorph 
version 7.8 (Molecular Devices Corporation, San Jose, CA). 60-150 cells were analyzed 
per genotype and condition. 
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8.2.7 Cytospins 
150,000 peritoneal exudate cells were centrifuged at 1000 rpm onto glass 
microscope slides for 5 min. Slides were dried for 1hr in the dark. Slides were stained with 
Giemsa May-Grünwald reagents (Sigma). Slides were dried overnight and sealed. 500 cells 
were counted per slide.  
 
8.2.8 ELISA (in vitro) 
BMDMs were pre-treated for 1hr with IETD-fmk (500 μM) or zVAD-fmk (100 
μM) where indicated and stimulated with 100 ng/mL E. coli LPS (Sigma) or 1 μM CpG 
(IDT) for 5 hours unless otherwise indicated. Release of proinflammatory cytokines was 
measured by enzyme-linked immunosorbent assay (ELISA) using capture and detection 
antibodies against IL-6 (BD), IL-12p40 (BD) or TNFα (BioLegend).  
 
8.2.9 ELISA (in vivo) 
Whole blood was isolated via cardiac puncture, incubated at 4C for 3hrs and spun 
at 15,000 g for 13 min at 4C. Serum was isolated and cytokines was measured by enzyme-
linked immunosorbent assay (ELISA) using capture and detection antibodies against IL-
12p40 (BD) or TNFα (BioLegend). 
 
8.2.10 FasL stimulation of thymocytes and thymocyte characterization  
1.5x105 thymocytes were plated in a 96-well flat bottom plate, and treated with 
cycloheximide (25μg/mL) and anti-CD95 (Jo2, BD) at the indicated concentrations for 
24hrs. Cells were treated with staurosporine (10μM) where indicated for 8hrs. Cells were 
harvested and washed once in 4C sterile PBS. Cells were stained in Annexin V (Thermo 
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Fisher) for 15 min, washed with Annexin binding buffer. Cells were stained with 7AAD 
(Thermo Fisher), placed on ice and run immediately after staining.  
Thymi were isolated from mice and processed into a single cell suspensions. 2x106 
thymocytes were plated in 96-well U-bottom plates in sterile PBS and stained for viability 
(Zombie Aqua, BioLegend) and then  for CD4 (Bio Legend Clone-RM4-5), CD11b 
(BioLegend Clone-M1/70), CD11c (BioLegend Clone-3.9), CD19 (BioLegend Clone-
1D3), CD49 (BioLegend Clone-9C10 (MFR4.B)), Gr-1 (BioLegend Clone-RB6-8C5), 
CD25 (BioLegend Clone-PC61), TCRβ (BioLegend Clone-H57-597), CD8 (BioLegend 
Clone-RPA-T8), CD44 (BioLegend Clone-BJ18), c-Kit (BioLegend Clone-2B8), CD5 
(BioLegend Clone-53-7.3), and CD69 (BioLegend Clone-H1.2F3).  
 
8.2.11 Flow cytometry (in vitro) 
BMDMs were plated in 96 well-u-bottom plates and pre-treated with zVAD-fmk 
(100 μM) for 1 hr prior to PAMP stimulation, where indicated. BFA and monensin were 
added 1 hr later and samples were harvested for analysis 4–5 hrs later. Cells were washed 
with PBS, stained for viability (Zombie Yellow, BioLegend),  Il-12p40 (BD Clone-C15.6) 
and pro-IL-1β(Thermo Fisher Clone NJTEN3). BMDMs were gated on live singlets. For 
hc- experiments involving hc-Rel transfection, BMDMs were plated in 6-well suspension 
dishes after electroporation. Electroporated BMDMs were stimulated with PAMPs 2 hrs 
after electroporation, and brefeldin A/monensin (Sigma, BD) were added 1hr after PAMP 
stimulation. Cells were harvested 3 hours later into PBS containing 2mM EDTA. Cells 
were washed with PBS, stained for viability (Zombie Yellow, BioLegend), Il-12p40 (BD 
Clone-C15.6), and pro-IL-1β(Thermo Fisher Clone NJTEN3). 
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8.2.12 Flow cytometry (in vivo) 
mLNs and PECs were isolated in 4C sterile PBS. RBCs were lysed in 1x ACK 
buffer for 3min at room temperature. 1-2x106 PECs were plated in 96-well U-bottom T/C 
treated plates in cDMEM with β-mercaptoethanol, Pen-Strep,  and brefeldin A/monensin 
(Sigma, BD) for 6hrs. 4-5x106 mLN cells were plated in 96-well U-bottom T/C treated 
plates in cDMEM with β-mercaptoethanol, Pen-Strep,  and brefeldin A/monensin (Sigma, 
BD) for 6hrs.  Cells were washed with PBS, stained for viability (Zombie Aqua or Zombie 
Yellow, BioLegend) and stained for CD45.1 (BioLegend Clone-A20), CD45.2 (BioLegend 
Clone-104), B220 (BioLegend Clone-RA3-6B2), CD3 (BioLegend Clone-17A2), CD19 
(BioLegend Clone-1D3), NK1.1 (BioLegend Clone-PK136), MHCII (BioLegend Clone-
M5), Ly6G (BioLegend Clone-1A8), Ly6C (BioLegend Clone-HK1.4), CD11b 
(BioLegend Clone-M1/70), CD11c (BioLegend Clone-3.9), CD64 (BioLegend Clone-
10.1), Il-12p40 (BD Clone-C15.6). Cells were gated on live singlets. 
 
8.2.13 RNA-seq  
1x106 BMDMs per well were plated in 6-well T/C-treated dishes and placed in a 
5% CO2 37°C incubator for 16 hours. BMDMs were stimulated with LPS (100 ng/mL) or 
CpG (1μM) for 0, 2, or 6 hrs. RNA was isolated using the RNeasy Mini Kit (Qiagen) and 
processed per the manufacturer’s instructions. RNA-seq libraries were prepared using the 
TruSeq Stranded Total RNA LT Kit with Ribo-Zero Gold, according to the manufacturer’s 
instructions. Samples were run on Illumina NextSeq 500 to generate 75-base pair, single-
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end reads with a Q30 score of ~80%, resulting in 25–50 million fragments/sample. 
Bioinformatic analyses were carried out as previously described[233]. Briefly, data 
analyses were performed using the statistical computing environment R (v3.5.1), RStudio 
(v1.1.456), and the Bioconductor suite of packages for R (http://www.bioconductor.org) 
[234]. Fastq files were mapped to the mouse transcriptome (Ensembl, mouse cDNA 
GRCh38) using Kallisto [235]. Reads were annotated with EnsemblDB [236] and 
EnsDb.Mmusculus.v79 [237], and Tximport [238] was used to summarize transcripts to 
genes. Data were log2 transformed and scaled using weighted trimmed mean of M-values 
with (edgeR [239]). The prcomp function was used to perform principal component 
analyses (PCA) on normalized data. Unsupervised hierarchical clustering and PCA plots 
were visualized using ggplot2 [240]. For differential gene expression analysis, data were 
filtered to remove unexpressed and lowly expressed (>1 count per million (cpm) across 2 
or more samples. Differentially expressed genes (false discovery rate < 0.05 and absolute 
log2 fold change >= 0.59), were identified using limma [241]. Heatmaps were created and 
visualized using gplots [242]. Gene Ontology (GO) was performed using the Database for 
Annotation, Visualization and Integration of Data (DAVID) [243]. HOMER transcription 
factor motif analysis [61]was performed on a set of genes that were identified to be caspase-
8-dependent by the analysis described above. Raw data is available on the Gene Expression 
Omnibus (GEO) (accession number pending). 
 
8.2.14 RT-qPCR 
1x106 BMDMs/well were plated in 6-well T/C-treated dishes 16 hrs before the 
experiment. Cells were pre-treated with with IETD-fmk (500 μM) or zVAD-fmk (100 μM) 
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prior to LPS (100 ng/mL) or CpG(1 μM)  stimulation. Cells were harvested 2 hours post 
stimulation and lysed in Trizol Reagent (Invitrogen/Thermo Fisher) and RNA was 
extracted using the phenol/chloroform extraction method. RNA was resuspended in 
RNAse-free water and cDNA synthesis was performed using High Capacity RNA to cDNA 
kit (Thermo Fisher) as per the manufacturer’s instructions. qPCR was run using Power 
Sybr Green Master Mix (Thermo Fisher) on a QuantStudio Flex6000 (Thermo Fisher). 
Primer sequences used are listed in the Appendix.  
 
8.2.15 Western Blots 
BMDMs were seeded in TC-treated 48, 24 or 12 well plates. Where indicated 
IETD-fmk (500 μM) or zVAD-fmk (100 μM) was used to inhibit caspase-8 activity for 1 
hr before LPS (100ng/mL) or CpG(1 μM) stimulation. Cells were lysed at the indicated 
times in lysis buffer (20 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 
1mM EDTA, pH7.5) plus 1x complete protease inhibitor cocktail (Roche) and 1x sample 
buffer (25 mM Tris, 2% SDS, 10% glycerol, 0.012% bromophenol blue, 0.2% β-
mercaptoethanol). Lysates were boiled at 110°C, spun at full speed for 5 minutes, run on 
4-12% polyacrylamide gels (Invitrogen), and transferred to PVDF (Millipore). Membranes 
were immunoblotted using the following primary antibodies: β-Actin (Sigma #A228, 
1:5000), cRel (Santa Cruz sc-71X, 1:100), p65 (CST #8242 1:1000), IκBα (CST #9242, 
1:1000), IκBε (Novus Biologics #AF4637, 1ug/mL) IκBβ (Novus Biologics #AF5225, 
1ug/mL), pIKKα/β (CST #2697, 1:1000), IKKβ (CST #8943, 1:1000), p-p38 (CST 
#9215,1:1000),  p38 (CST #9212, 1:1000), GFP (Abcam ab6556, 1:1000), CYLD (Thermo 
#43-700, 1:100), CNBP (Santa Cruz sc-515387, 1:100), HDAC1 (CST #34589S, 1:1000), 
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Tubulin (Thermo #A11126, 1:5000), TAK1 (CST 1:1000), pTAK1 (Abcam pS439 
1:1000), TBK1 (CST 1:000), pTBK1 (CST pS172 1:1000). Species specific HRP-
conjugated secondary antibodies were used for each antibody (1:5000). Membranes were 
developed using Pierce ECL Plus and SuperSignal West Femto Maximum Sensitivity 
Substrate (Fisher Scientific) according to the manufacturer’s instructions. 
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8.3 Quantification and statistical analysis 
Statistical significance for experiments with two groups was calculated using 
Student’s two-tailed unpaired t-test. In the case of paired replicate experiments statistical 
significance was calculated using  Student’s two-tailed paired t-test. Adjusted p-values 
were calculated using Prism 5.0 from GraphPad. n.s. denotes not significant; *, **, ***, 
and **** illustrate p-values of 0.05, 0.01, 0.001, and 0.0001 respectively. Error bars 
indicate ± SEM of at least three replicates. Investigators were not blinded to experimental 
groups. 
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8.4 Appendix 
Table S1. Primer list for ChIP qPCR and cDNA amplification.    
 
  
Gene 
Target Type Forward Reverse 
Csf2 cDNA GGCCTTGGAAGCATGTAGAGG GAGAACTCGTTAGAGACGACTT 
Gapdh cDNA CTCCCACTCTTCCACCTTCG CCACCACCCTGTTGCTGTAG 
Il12b cDNA TTGAAAGGCTGGGTATCGGT GAATTTCTGTGTGGCACTGG 
Il1b cDNA CCTCTGATGGGCAACCACTT TTCATCCCCCACACGTTGAC 
Il1a cDNA CGAAGACTACAGTTCTGCCATT GACGTTTCAGAGGTTCTCAGAG 
Il4i1 cDNA TCCAGCTTGAACCCTATTGAGA GTCCTGCATCACTGAGCATCT 
Il6 cDNA TCACTGGAGCCTCGAATGTC GTGAGGAAGGCTGTGCATTG 
Tnfsf9 cDNA CGGCGCTCCTCAGAGATAC ATCCCGAACATTAACCGCAGG 
Gapdh ChIP GGTCCAAAGAGAGGGAGGAG GCCCTGCTTATCCAGTCCTA 
Hbb-bs ChIP GCATGGAAGACAGGACAATC GTGGGAGGAGTGTACAAGGA 
Il12b ChIP GGGGAGGGAGGAACTTCTTA CTTTCTGATGGAAACCCAAAG 
Il1b ChIP CCCACCCTTCAGTTTTGTTG CTTGTTTTCCCTCCCTTGTTT 
Il6 ChIP AATGTGGGATTTTCCCATGA GCTCCAGAGCAGAATGAGCTA 
Tnf ChIP GATTCCTTGATGCCTGGGTGTC GAGCTTCTGCTGGCTGGCTGT 
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